VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q41591689  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241120235752.0
008     241120nneanz||abbn n and d
035 ‎‡a  (WKP)Q41591689‏
024 ‎‡a  0000-0002-0387-880X‏ ‎‡2  orcid‏
024 ‎‡a  36078972900‏ ‎‡2  scopus‏
024 ‎‡a  56489064900‏ ‎‡2  scopus‏
035 ‎‡a  (OCoLC)Q41591689‏
046 ‎‡f  19600000‏
100 0 ‎‡a  بيتر بي. جونز‏ ‎‡9  ar‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Peter B. Jones‏ ‎‡9  es‏ ‎‡9  sl‏ ‎‡9  ast‏
400 0 ‎‡a  পিটার বি. জোন্স‏ ‎‡c  গবেষক‏ ‎‡9  bn‏
400 0 ‎‡a  Peter B. Jones‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Peter B. Jones‏ ‎‡c  onderzoeker‏ ‎‡9  nl‏
670 ‎‡a  Author's 5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence‏
670 ‎‡a  Author's A class-contrastive human-interpretable machine learning approach to predict mortality in severe mental illness‏
670 ‎‡a  Author's A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia‏
670 ‎‡a  Author's A Computational Analysis of Abnormal Belief Updating Processes and Their Association With Psychotic Experiences and Childhood Trauma in a UK Birth Cohort‏
670 ‎‡a  Author's A longitudinal typology of symptoms of depression and anxiety over the life course‏
670 ‎‡a  Author's A novel Alzheimer disease locus located near the gene encoding tau protein.‏
670 ‎‡a  Author's A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence‏
670 ‎‡a  Author's A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis‏
670 ‎‡a  Author's A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence‏
670 ‎‡a  Author's A population-based study of genetic variation and psychotic experiences in adolescents‏
670 ‎‡a  Author's A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data‏
670 ‎‡a  Author's A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.‏
670 ‎‡a  Author's A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine‏
670 ‎‡a  Author's Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis.‏
670 ‎‡a  Author's Acute and transient psychotic disorders: precursors, epidemiology, course and outcome.‏
670 ‎‡a  Author's Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.‏
670 ‎‡a  Author's Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome‏
670 ‎‡a  Author's Adolescent friendships predict later resilient functioning across psychosocial domains in a healthy community cohort‏
670 ‎‡a  Author's Adolescent self-control predicts midlife hallucinatory experiences: 40-year follow-up of a national birth cohort‏
670 ‎‡a  Author's Adolescent self-organization predicts midlife memory in a prospective birth cohort study‏
670 ‎‡a  Author's Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study.‏
670 ‎‡a  Author's Aggressive incidents in first-episode psychosis.‏
670 ‎‡a  Author's Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.‏
670 ‎‡a  Author's Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia‏
670 ‎‡a  Author's Appraisals of stressors and common mental disorder from early to mid-adulthood in the 1946 British birth cohort‏
670 ‎‡a  Author's Assessment of posttraumatic symptoms in patients with first-episode psychosis‏
670 ‎‡a  Author's Assessment of remission in schizophrenia with the CGI and CGI-SCH scales‏
670 ‎‡a  Author's Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up‏
670 ‎‡a  Author's Association between common early-childhood infection and subsequent depressive symptoms and psychotic experiences in adolescence: a population-based longitudinal birth cohort study‏
670 ‎‡a  Author's Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966‏
670 ‎‡a  Author's Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort.‏
670 ‎‡a  Author's Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review‏
670 ‎‡a  Author's Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: Findings from the ALSPAC cohort.‏
670 ‎‡a  Author's Association of cannabis use with prodromal symptoms of psychosis in adolescence‏
670 ‎‡a  Author's Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls‏
670 ‎‡a  Author's Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study‏
670 ‎‡a  Author's Associations between early development and outcome in schizophrenia — A 35-year follow-up of the Northern Finland 1966 Birth Cohort‏
670 ‎‡a  Author's Authors' reply‏
670 ‎‡a  Author's Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study‏
670 ‎‡a  Author's Autoimmune diseases in the pedigrees of schizophrenic and control subjects‏
670 ‎‡a  Author's Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes‏
670 ‎‡a  Author's Biological and psychosocial risk factors for psychotic major depression.‏
670 ‎‡a  Author's Birth cohort studies in psychiatry: beginning at the beginning‏
670 ‎‡a  Author's Birth order and risk for schizophrenia: a 31-year follow-up of the Northern Finland 1966 Birth Cohort‏
670 ‎‡a  Author's Brain-behaviour modes of covariation in healthy and clinically depressed young people‏
670 ‎‡a  Author's Brain micro-architecture and disinhibition: a latent phenotyping study across 33 impulsive and compulsive behaviours‏
670 ‎‡a  Author's Brain structure in different psychosis risk groups in the Northern Finland 1986 Birth Cohort‏
670 ‎‡a  Author's Breaking the web: life beyond the at-risk mental state for psychosis‏
670 ‎‡a  Author's Cannabis and acute psychosis.‏
670 ‎‡a  Author's Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales‏
670 ‎‡a  Author's Cannabis use and outcome of recent onset psychosis‏
670 ‎‡a  Author's Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review‏
670 ‎‡a  Author's Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study‏
670 ‎‡a  Author's Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers‏
670 ‎‡a  Author's Caregiving in first-episode psychosis: social characteristics associated with perceived ‘burden’ and associations with compulsory treatment‏
670 ‎‡a  Author's Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: A nine-year follow-up in the Northern Finland Birth Cohort study 1966.‏
670 ‎‡a  Author's Child development risk factors for adult schizophrenia in the British 1946 birth cohort‏
670 ‎‡a  Author's Childhood adversity subtypes and depressive symptoms in early and late adolescence‏
670 ‎‡a  Author's Childhood central nervous system infections and risk for schizophrenia‏
670 ‎‡a  Author's Childhood cognitive ability and adult mental health in the British 1946 birth cohort‏
670 ‎‡a  Author's Childhood cognitive function and adult psychopathology: associations with psychotic and non-psychotic symptoms in the general population‏
670 ‎‡a  Author's Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study‏
670 ‎‡a  Author's Childhood infection and adult schizophrenia: a meta-analysis of population-based studies‏
670 ‎‡a  Author's Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort‏
670 ‎‡a  Author's Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives‏
670 ‎‡a  Author's Childhood trauma and cognitive function in first-episode affective and non-affective psychosis‏
670 ‎‡a  Author's Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study.‏
670 ‎‡a  Author's Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis‏
670 ‎‡a  Author's Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis‏
670 ‎‡a  Author's Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR.‏
670 ‎‡a  Author's Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings‏
670 ‎‡a  Author's Cognitive reserve in neuropsychiatry.‏
670 ‎‡a  Author's Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study‏
670 ‎‡a  Author's Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study (The WAYS Study).‏
670 ‎‡a  Author's Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project‏
670 ‎‡a  Author's Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?‏
670 ‎‡a  Author's Commentary on: Mendelson T & Eaton WW. Recent advances in the prevention of mental disorders. SPPE‏
670 ‎‡a  Author's Commentary on: Mendelson T & Eaton WW. Recent advances in the prevention of mental disorders. SPPE (2018)‏
670 ‎‡a  Author's Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence‏
670 ‎‡a  Author's Comparative effectiveness of cognitive therapies delivered face-to-face or over the telephone: an observational study using propensity methods‏
670 ‎‡a  Author's Comparing time use in individuals at different stages of psychosis and a non-clinical comparison group‏
670 ‎‡a  Author's Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial‏
670 ‎‡a  Author's Compulsivity and impulsivity traits linked to attenuated developmental frontostriatal myelination trajectories‏
670 ‎‡a  Author's Correction: Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort‏
670 ‎‡a  Author's Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.‏
670 ‎‡a  Author's Cost of improving Access to Psychological Therapies (IAPT) programme: an analysis of cost of session, treatment and recovery in selected Primary Care Trusts in the East of England region‏
670 ‎‡a  Author's Criminal offending and distinguishing features of offenders among persons experiencing a first episode of psychosis‏
670 ‎‡a  Author's Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes‏
670 ‎‡a  Author's Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study‏
670 ‎‡a  Author's Cultural differences in pathways to care, service use and treated outcomes‏
670 ‎‡a  Author's Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study‏
670 ‎‡a  Author's Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study‏
670 ‎‡a  Author's Default mode network in young people with familial risk for psychosis--the Oulu Brain and Mind study‏
670 ‎‡a  Author's Defining the needs of patients with intellectual disabilities in the high security psychiatric hospitals in England.‏
670 ‎‡a  Author's Depressive symptoms during adolescence: comparison between epidemiological and high risk sampling‏
670 ‎‡a  Author's Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule‏
670 ‎‡a  Author's Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS).‏
670 ‎‡a  Author's Developmental cognitive neuroscience using latent change score models: A tutorial and applications.‏
670 ‎‡a  Author's Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis‏
670 ‎‡a  Author's Deviant intrauterine growth and risk of schizophrenia: a 34-year follow-up of the Northern Finland 1966 Birth Cohort‏
670 ‎‡a  Author's Diagnostic change 10 years after a first episode of psychosis‏
670 ‎‡a  Author's Diagnostic stability and outcome after first episode psychosis‏
670 ‎‡a  Author's Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study‏
670 ‎‡a  Author's Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort‏
670 ‎‡a  Author's Differential relationship between neurological and cognitive dysfunction in first episode psychosis patients and in healthy individuals‏
670 ‎‡a  Author's Differing patterns of brain structural abnormalities between black and white patients with their first episode of psychosis‏
670 ‎‡a  Author's Discharged from special hospital under restrictions: a comparison of the fates of psychopaths and the mentally ill‏
670 ‎‡a  Author's Disease-relevant autoantibodies in first episode schizophrenia‏
670 ‎‡a  Author's Do obstetric complications cause the earlier age at onset in male than female schizophrenics?‏
670 ‎‡a  Author's Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring?‏
670 ‎‡a  Author's Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis‏
670 ‎‡a  Author's Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study‏
670 ‎‡a  Author's Duration of untreated psychosis and neuropsychological function in first episode psychosis.‏
670 ‎‡a  Author's Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.‏
670 ‎‡a  Author's Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.‏
670 ‎‡a  Author's Early development, stress and depression across the life course: pathways to depression in a national British birth cohort‏
670 ‎‡a  Author's Early intervention for incipient insanity: early notions from the 19(th) century English literature.‏
670 ‎‡a  Author's Early intervention in psychosis: keeping the body in mind‏
670 ‎‡a  Author's Early intervention services in psychosis: from evidence to wide implementation.‏
670 ‎‡a  Author's Early risk factors and adult person--environment relationships in affective disorder.‏
670 ‎‡a  Author's Early risk factors for suicide in an epidemiological first episode psychosis cohort‏
670 ‎‡a  Author's Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.‏
670 ‎‡a  Author's Educational consequences of mental disorders treated in hospital. A 31-year follow-up of the Northern Finland 1966 Birth Cohort.‏
670 ‎‡a  Author's Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study‏
670 ‎‡a  Author's Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes‏
670 ‎‡a  Author's Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes‏
670 ‎‡a  Author's Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study‏
670 ‎‡a  Author's Effects of cannabis use on outcomes of psychotic disorders: systematic review‏
670 ‎‡a  Author's Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children‏
670 ‎‡a  Author's Effects of modafinil on cognitive functions in first episode psychosis‏
670 ‎‡a  Author's Effects of modafinil on emotional processing in first episode psychosis‏
670 ‎‡a  Author's Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls‏
670 ‎‡a  Author's Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms‏
670 ‎‡a  Author's Epidemiological aspects of migration and mental illness‏
670 ‎‡a  Author's Epidemiological challenges in systematic reviews‏
670 ‎‡a  Author's Establishing a Theory-Based Multi-Level Approach for Primary Prevention of Mental Disorders in Young People‏
670 ‎‡a  Author's Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study‏
670 ‎‡a  Author's Ethnicity and mental health: the example of schizophrenia and related psychoses in migrant populations in the Western world‏
670 ‎‡a  Author's Ethnicity and mental health: the example of schizophrenia in migrant populations across Europe‏
670 ‎‡a  Author's Ethnicity and Mental Health: The Example of Schizophrenia in the African-Caribbean Population in Europe‏
670 ‎‡a  Author's Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample‏
670 ‎‡a  Author's Examining evidence for neighbourhood variation in the duration of untreated psychosis.‏
670 ‎‡a  Author's Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence‏
670 ‎‡a  Author's Exercise and depressive symptoms in adolescents: a longitudinal cohort study‏
670 ‎‡a  Author's Explaining sex differences in course and outcome in the functional psychoses‏
670 ‎‡a  Author's Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years‏
670 ‎‡a  Author's Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs‏
670 ‎‡a  Author's Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort‏
670 ‎‡a  Author's Family history of autoimmune diseases in psychosis‏
670 ‎‡a  Author's First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply‏
670 ‎‡a  Author's Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence.‏
670 ‎‡a  Author's Friendships and Family Support Reduce Subsequent Depressive Symptoms in At-Risk Adolescents‏
670 ‎‡a  Author's Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia‏
670 ‎‡a  Author's Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis‏
670 ‎‡a  Author's Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study‏
670 ‎‡a  Author's Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England.‏
670 ‎‡a  Author's Gender differences in neuropsychological performance across psychotic disorders--a multi-centre population based case-control study‏
670 ‎‡a  Author's Gender differences in the association between childhood abuse and psychosis.‏
670 ‎‡a  Author's Gender differences in the association between childhood physical and sexual abuse, social support and psychosis‏
670 ‎‡a  Author's Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children‏
670 ‎‡a  Author's Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.‏
670 ‎‡a  Author's General distress, hopelessness-suicidal ideation and worrying in adolescence: concurrent and predictive validity of a symptom-level bifactor model for clinical diagnoses.‏
670 ‎‡a  Author's Genes and the social environment‏
670 ‎‡a  Author's Genes, viruses and neurodevelopmental schizophrenia‏
670 ‎‡a  Author's Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review‏
670 ‎‡a  Author's Gray matter abnormalities associated with duration of untreated psychosis‏
670 ‎‡a  Author's Grey matter abnormalities in first-episode schizophrenia and affective psychosis‏
670 ‎‡a  Author's Grey matter correlates of minor physical anomalies in the AeSOP first-episode psychosis study‏
670 ‎‡a  Author's Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes‏
670 ‎‡a  Author's Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort‏
670 ‎‡a  Author's Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations‏
670 ‎‡a  Author's If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations‏
670 ‎‡a  Author's Illicit substance use and its correlates in first episode psychosis‏
670 ‎‡a  Author's Immune dysregulation among students exposed to exam stress and its mitigation by mindfulness training: findings from an exploratory randomised trial‏
670 ‎‡a  Author's Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series‏
670 ‎‡a  Author's Impact of cognitive therapy on internalised stigma in people with at-risk mental states‏
670 ‎‡a  Author's Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study‏
670 ‎‡a  Author's Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.‏
670 ‎‡a  Author's Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling‏
670 ‎‡a  Author's Improving access to psychological therapies and older people: findings from the Eastern Region‏
670 ‎‡a  Author's Incentive motivation in first-episode psychosis: a behavioural study‏
670 ‎‡a  Author's Incidence and distribution of first-episode mania by age: results from a 35-year study.‏
670 ‎‡a  Author's Incidence of bipolar affective disorder in three UK cities: results from the AESOP study.‏
670 ‎‡a  Author's Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses‏
670 ‎‡a  Author's Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study‏
670 ‎‡a  Author's Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom.‏
670 ‎‡a  Author's Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study‏
670 ‎‡a  Author's Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study‏
670 ‎‡a  Author's Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study‏
670 ‎‡a  Author's Infant developmental milestones and subsequent cognitive function‏
670 ‎‡a  Author's Infant motor development and adult cognitive functions in schizophrenia.‏
670 ‎‡a  Author's Infant motor development is associated with adult cognitive categorisation in a longitudinal birth cohort study.‏
670 ‎‡a  Author's Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment‏
670 ‎‡a  Author's Insight, grey matter and cognitive function in first-onset psychosis‏
670 ‎‡a  Author's Interaction between parental psychosis and early motor development and the risk of schizophrenia in a general population birth cohort‏
670 ‎‡a  Author's Interplay between childhood physical abuse and familial risk in the onset of psychotic disorders‏
670 ‎‡a  Author's Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity?‏
670 ‎‡a  Author's Investigating the genetic architecture of general and specific psychopathology in adolescence‏
670 ‎‡a  Author's IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up.‏
670 ‎‡a  Author's Is prematurity associated with adult cognitive outcome and brain structure?‏
670 ‎‡a  Author's Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research‏
670 ‎‡a  Author's Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis?‏
670 ‎‡a  Author's Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentric EU-GEI Case-Control Study‏
670 ‎‡a  Author's Life events before psychotic episodes: do clinical and social variables affect the relationship?‏
670 ‎‡a  Author's Life mapping: a 'Therapeutic Document' approach to needs assessment‏
670 ‎‡a  Author's Lifetime affect and midlife cognitive function: prospective birth cohort study‏
670 ‎‡a  Author's Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study‏
670 ‎‡a  Author's Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.‏
670 ‎‡a  Author's Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis‏
670 ‎‡a  Author's Linking the developmental and degenerative theories of schizophrenia: association between infant development and adult cognitive decline‏
670 ‎‡a  Author's Links between creativity and mental disorder‏
670 ‎‡a  Author's Lithium in bipolar and other affective disorders: prescribing practice in the UK.‏
670 ‎‡a  Author's Lithium is more effective than placebo for preventing all relapses in patients with bipolar but not unipolar disorder‏
670 ‎‡a  Author's Longitudinal associations between childhood and adulthood externalizing and internalizing psychopathology and adolescent substance use.‏
670 ‎‡a  Author's Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication‏
670 ‎‡a  Author's Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort‏
670 ‎‡a  Author's Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function‏
670 ‎‡a  Author's Lower prevalence of pre-morbid neurological illness in African-Caribbean than White psychotic patients in England.‏
670 ‎‡a  Author's Maternal separation at birth and schizophrenia—a long-term follow-up of the Finnish Christmas Seal Home Children‏
670 ‎‡a  Author's Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D.‏
670 ‎‡a  Author's Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease‏
670 ‎‡a  Author's Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses‏
670 ‎‡a  Author's Migration and mental illness‏
670 ‎‡a  Author's Mindfulness-based programmes for mental health promotion in adults in non-clinical settings: protocol of an individual participant data meta-analysis of randomised controlled trials‏
670 ‎‡a  Author's Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT‏
670 ‎‡a  Author's Minor physical anomalies across ethnic groups in a first episode psychosis sample‏
670 ‎‡a  Author's Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity.‏
670 ‎‡a  Author's Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables‏
670 ‎‡a  Author's Minor physical anomalies in schizophrenia: is age a confounding factor?‏
670 ‎‡a  Author's Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain‏
670 ‎‡a  Author's Modelling the interplay between childhood and adult adversity in pathways to psychosis: initial evidence from the AESOP study‏
670 ‎‡a  Author's Mokken scale analysis of mental health and well-being questionnaire item responses: a non-parametric IRT method in empirical research for applied health researchers‏
670 ‎‡a  Author's Mood, anxiety and psychotic phenomena measure a common psychopathological factor‏
670 ‎‡a  Author's Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis‏
670 ‎‡a  Author's Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness‏
670 ‎‡a  Author's Mortality in first-contact psychosis patients in the U.K.: a cohort study.‏
670 ‎‡a  Author's Motor co-ordination deficits as predictors of schizophrenia among Finnish school children‏
670 ‎‡a  Author's Multilevel investigation of variation in HoNOS ratings by mental health professionals: a naturalistic study of consecutive referrals.‏
670 ‎‡a  Author's Multilevel ordinal factor analysis of the positive and negative syndrome scale‏
670 ‎‡a  Author's Multilevel ordinal factor analysis of the positive and negative syndrome scale (PANSS).‏
670 ‎‡a  Author's Negative cognition, affect, metacognition and dimensions of paranoia in people at ultra-high risk of psychosis: a multi-level modelling analysis.‏
670 ‎‡a  Author's Neighbourhood-level effects on psychoses: re-examining the role of context‏
670 ‎‡a  Author's Neighbourhood variation in the incidence of psychotic disorders in Southeast London‏
670 ‎‡a  Author's Neuregulin-1 genotype is associated with structural differences in the normal human brain‏
670 ‎‡a  Author's Neurocomputational mechanisms underpinning aberrant social learning in young adults with low self-esteem‏
670 ‎‡a  Author's Neurological abnormalities and cognitive ability in first-episode psychosis.‏
670 ‎‡a  Author's Neuropsychological functioning in first-episode schizophrenia‏
670 ‎‡a  Author's Neuroticism as a risk factor for schizophrenia‏
670 ‎‡a  Author's No association between breast-feeding and adult psychosis in two national birth cohorts‏
670 ‎‡a  Author's No association of COMT (Val158Met) genotype with brain structure differences between men and women‏
670 ‎‡a  Author's Non-linear relationship between an index of social deprivation, psychiatric admission prevalence and the incidence of psychosis‏
670 ‎‡a  Author's Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial‏
670 ‎‡a  Author's Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1).‏
670 ‎‡a  Author's Obstetric complications and familial morbid risk of psychiatric disorders‏
670 ‎‡a  Author's Obstetric complications and schizophrenia: historical and meta-analytic review‏
670 ‎‡a  Author's Oligodendrocyte dysfunction in schizophrenia and bipolar disorder‏
670 ‎‡a  Author's Onset-age of bipolar disorders at six international sites‏
670 ‎‡a  Author's Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort‏
670 ‎‡a  Author's Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort‏
670 ‎‡a  Author's Parental separation, loss and psychosis in different ethnic groups: a case-control study‏
670 ‎‡a  Author's Parity of esteem begins at home: translating empirical psychiatric research into effective public mental health.‏
670 ‎‡a  Author's Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. Report from the AESOP study‏
670 ‎‡a  Author's Pathways to care and ethnicity. 2: Source of referral and help-seeking. Report from the AESOP study‏
670 ‎‡a  Author's Pathways to violent behavior during first-episode psychosis: a report from the UK National EDEN Study‏
670 ‎‡a  Author's Perceptions of disadvantage, ethnicity and psychosis‏
670 ‎‡a  Author's Perinatal and childhood risk factors for later criminality and violence in schizophrenia. Longitudinal, population-based study‏
670 ‎‡a  Author's Personality disorder in an Early Intervention Psychosis cohort: Findings from the Social Epidemiology of Psychoses in East Anglia (SEPEA) study‏
670 ‎‡a  Author's Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population‏
670 ‎‡a  Author's Poor premorbid school performance, but not severity of illness, predicts cognitive decline in schizophrenia in midlife‏
670 ‎‡a  Author's Postwar environment and long-term mental health problems in former child soldiers in Northern Uganda: the WAYS study‏
670 ‎‡a  Author's Potential gains in life expectancy from reducing amenable mortality among people diagnosed with serious mental illness in the United Kingdom‏
670 ‎‡a  Author's Pre-morbid fertility in psychosis: findings from the AESOP first episode study‏
670 ‎‡a  Author's Pre-training inter-rater reliability of clinical instruments in an international psychosis research project‏
670 ‎‡a  Author's Precursors and correlates of transient and persistent longitudinal profiles of psychotic experiences from late childhood through early adulthood‏
670 ‎‡a  Author's Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department.‏
670 ‎‡a  Author's Predictors of schizophrenia--a review‏
670 ‎‡a  Author's Prenatal maternal influenza and schizophrenia in offspring: What does this tell us about fetal programming of chronic disease?‏
670 ‎‡a  Author's Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study.‏
670 ‎‡a  Author's Prevalence of depression in older people in England and Wales: the MRC CFA Study‏
670 ‎‡a  Author's Profiles of family-focused adverse experiences through childhood and early adolescence: the ROOTS project a community investigation of adolescent mental health‏
670 ‎‡a  Author's Prospective cohort study of mental health during imprisonment‏
670 ‎‡a  Author's Psychiatric morbidity, functioning and quality of life in young people at clinical high risk for psychosis‏
670 ‎‡a  Author's Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics.‏
670 ‎‡a  Author's Psychoses, ethnicity and socio-economic status.‏
670 ‎‡a  Author's Psychosis incidence through the prism of early intervention services‏
670 ‎‡a  Author's Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study‏
670 ‎‡a  Author's Psychotic symptoms in young people without psychotic illness: mechanisms and meaning‏
670 ‎‡a  Author's Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study‏
670 ‎‡a  Author's Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia‏
670 ‎‡a  Author's Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study‏
670 ‎‡a  Author's Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).‏
670 ‎‡a  Author's Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study‏
670 ‎‡a  Author's Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort.‏
670 ‎‡a  Author's Reassessing the long-term risk of suicide after a first episode of psychosis‏
670 ‎‡a  Author's Record linkage of domestic assault victims between an emergency department and the police‏
670 ‎‡a  Author's Reducing duration of untreated psychosis: care pathways to early intervention in psychosis services‏
670 ‎‡a  Author's Reinforcement and reversal learning in first-episode psychosis.‏
670 ‎‡a  Author's Relationship of birth season to clinical features, family history, and obstetric complications in schizophrenia‏
670 ‎‡a  Author's Reliability and comparability of psychosis patients' retrospective reports of childhood abuse‏
670 ‎‡a  Author's Response initiation in young adults at risk for psychosis in the Northern Finland 1986 Birth Cohort‏
670 ‎‡a  Author's Risk factors for onset and persistence of psychosis.‏
670 ‎‡a  Author's Satisfaction with inpatient treatment for first-episode psychosis among different ethnic groups: a report from the UK AeSOP study.‏
670 ‎‡a  Author's Schizophrenia and other psychotic disorders in Caribbean-born migrants and their descendants in England: systematic review and meta-analysis of incidence rates, 1950-2013‏
670 ‎‡a  Author's Schizophrenia in the offspring of antenatally depressed mothers: a 31-year follow-up of the Northern Finland 1966 Birth Cohort‏
670 ‎‡a  Author's Schizophrenia in the Offspring of Antenatally Depressed Mothers in the Northern Finland 1966 Birth Cohort: Relationship to Family History of Psychosis‏
670 ‎‡a  Author's Schizophrenia: social and environmental factors: implications for aetiology‏
670 ‎‡a  Author's Schizophrenia: The Epidemiological Horizon‏
670 ‎‡a  Author's Schizophrenia trial participation: perceived inclusion barriers and beliefs about antipsychotics‏
670 ‎‡a  Author's Schizophrenic patients and their first-degree relatives show an excess of mixed-handedness‏
670 ‎‡a  Author's Schizotypy-related magnetization of cortex in healthy adolescence is co-located with expression of schizophrenia risk genes:‏
670 ‎‡a  Author's School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort.‏
670 ‎‡a  Author's School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study‏
670 ‎‡a  Author's Selective deficits in semantic verbal fluency in patients with a first affective episode with psychotic symptoms and a positive history of mania‏
670 ‎‡a  Author's Self esteem and self agency in first episode psychosis: Ethnic variation and relationship with clinical presentation‏
670 ‎‡a  Author's Self-harm in first-episode psychosis‏
670 ‎‡a  Author's Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey‏
670 ‎‡a  Author's Service users' views of moving on from early intervention services for psychosis: a longitudinal qualitative study in primary care‏
670 ‎‡a  Author's Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort‏
670 ‎‡a  Author's Social deprivation, inequality, and the neighborhood-level incidence of psychotic syndromes in East London‏
670 ‎‡a  Author's Spatial and temporal mapping of neural activity associated with auditory hallucinations‏
670 ‎‡a  Author's Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations‏
670 ‎‡a  Author's Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systems.‏
670 ‎‡a  Author's Sporadic schizophrenia - another male preserve?‏
670 ‎‡a  Author's Stress and development of depression and heavy drinking in adulthood: moderating effects of childhood trauma‏
670 ‎‡a  Author's Structure and function of the corpus callosum in schizophrenia: What's the connection?‏
670 ‎‡a  Author's Substance use in a population-based clinic sample of people with first-episode psychosis‏
670 ‎‡a  Author's Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients.‏
670 ‎‡a  Author's Testing the association between the incidence of schizophrenia and social capital in an urban area‏
670 ‎‡a  Author's The antecedents of schizophrenia: a review of birth cohort studies‏
670 ‎‡a  Author's The association between domestic violence and self harm in emergency medicine patients‏
670 ‎‡a  Author's The association between pubertal status and depressive symptoms and diagnoses in adolescent females: A population-based cohort study.‏
670 ‎‡a  Author's The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s‏
670 ‎‡a  Author's The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial‏
670 ‎‡a  Author's The brain structural disposition to social interaction‏
670 ‎‡a  Author's The catechol-O-methyltransferase gene (COMT) and cognitive function from childhood through adolescence‏
670 ‎‡a  Author's The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls‏
670 ‎‡a  Author's The early impact of COVID-19 on mental health and community physical health services and their patients' mortality in Cambridgeshire and Peterborough, UK‏
670 ‎‡a  Author's The economic cost of pathways to care in first episode psychosis‏
670 ‎‡a  Author's The effect of the environment on symptom dimensions in the first episode of psychosis: a multilevel study.‏
670 ‎‡a  Author's The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment‏
670 ‎‡a  Author's The functional anatomy of auditory hallucinations in schizophrenia.‏
670 ‎‡a  Author's The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people‏
670 ‎‡a  Author's The influence of different types of war experiences on depression and anxiety in a Ugandan cohort of war-affected youth: the WAYS study‏
670 ‎‡a  Author's The influence of temperament on symptoms and functional outcome in people with psychosis in the Northern Finland 1966 Birth Cohort.‏
670 ‎‡a  Author's The persistence of developmental markers in childhood and adolescence and risk for schizophrenic psychoses in adult life. A 34-year follow-up of the Northern Finland 1966 birth cohort‏
670 ‎‡a  Author's The prevalence, diagnostic significance and demographic characteristics of Schneiderian first-rank symptoms in an epidemiological sample of first-episode psychoses‏
670 ‎‡a  Author's The Prevention of Schizophrenia--What Can We Learn From Eco-Epidemiology?‏
670 ‎‡a  Author's The progression of disorder-specific brain pattern expression in schizophrenia over 9 years‏
670 ‎‡a  Author's The security, clinical and social needs of patients in high security psychiatric hospitals in England‏
670 ‎‡a  Author's The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study‏
670 ‎‡a  Author's The structural brain correlates of neurological soft signs in healthy individuals‏
670 ‎‡a  Author's The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression‏
670 ‎‡a  Author's The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics‏
670 ‎‡a  Author's The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder.‏
670 ‎‡a  Author's Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort‏
670 ‎‡a  Author's Three-year outcome of first-episode psychoses in an established community psychiatric service.‏
670 ‎‡a  Author's Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects‏
670 ‎‡a  Author's Trauma exposure, PTSD and psychotic-like symptoms in post-conflict Timor Leste: an epidemiological survey‏
670 ‎‡a  Author's Trauma history characteristics associated with mental states at clinical high risk for psychosis‏
670 ‎‡a  Author's Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study‏
670 ‎‡a  Author's Use of the theory of planned behaviour to assess factors influencing the identification of individuals at ultra-high risk for psychosis in primary care‏
670 ‎‡a  Author's Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis‏
670 ‎‡a  Author's Verbal fluency in patients with schizophrenia and affective psychoses and their first-degree relatives‏
670 ‎‡a  Author's Views of Young People in Early Intervention Services for First-Episode Psychosis in England‏
670 ‎‡a  Author's Visuospatial learning and executive function are independently impaired in first-episode psychosis.‏
670 ‎‡a  Author's Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study‏
670 ‎‡a  Author's Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis‏
670 ‎‡a  Author's War experiences, general functioning and barriers to care among former child soldiers in Northern Uganda: the WAYS study‏
670 ‎‡a  Author's Which characteristics of schizophrenia predate psychosis?‏
670 ‎‡a  Author's White matter structure in young adults with familial risk for psychosis - The Oulu Brain and Mind Study‏
670 ‎‡a  Author's Why psychiatry can't afford to be neurophobic‏
670 ‎‡a  Author's Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study‏
670 ‎‡a  Author's Young people's views of UK mental health services‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/GRATEVE|275031‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/DNB|1011623552‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/NUKAT|n 2007133076‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/ISNI|0000000119535791‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/viaf/102237327‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/LC|no2003084028‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/processed/SUDOC|070986185‏
909 ‎‡a  (orcid) 000000020387880x‏ ‎‡9  1‏
909 ‎‡a  (scopus) 36078972900‏ ‎‡9  1‏
909 ‎‡a  (scopus) 56489064900‏ ‎‡9  1‏
912 ‎‡a  novelalzheimerdiseaselocuslocatednearthegeneencodingtauprotein‏ ‎‡A  A novel Alzheimer disease locus located near the gene encoding tau protein.‏ ‎‡9  1‏
912 ‎‡a  authorsreply‏ ‎‡A  Authors' reply‏ ‎‡9  1‏
912 ‎‡a  cognitivefunctioningthroughoutadulthoodandillnessstagesinindividualswithpsychoticdisordersandtheirunaffectedsiblings‏ ‎‡A  Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings‏ ‎‡9  1‏
912 ‎‡a  identifyinggeneenvironmentinteractionsinschizophreniacontemporarychallengesforintegratedlargescaleinvestigations‏ ‎‡A  Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations‏ ‎‡9  1‏
912 ‎‡a  metaanalysisof74046individualsidentifies11newsusceptibilitylociforalzheimersdisease‏ ‎‡A  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease‏ ‎‡9  1‏
919 ‎‡a  commentaryonmendelsontandeatonwwrecentadvancesinthepreventionofmentaldisorderssppe‏ ‎‡A  Commentary on: Mendelson T & Eaton WW. Recent advances in the prevention of mental disorders. SPPE‏ ‎‡9  2‏
919 ‎‡a  uknationalevaluationofthedevelopmentandimpactofearlyinterventionservicesthenationaledenstudiesstudyrationaledesignandbaselinecharacteristics‏ ‎‡A  The UK national evaluation of the development and impact of Early Intervention Services (the National EDEN studies): study rationale, design and baseline characteristics‏ ‎‡9  1‏
919 ‎‡a  varyingimpactoftypetimingandfrequencyofexposuretochildhoodadversityonitsassociationwithadultpsychoticdisorder‏ ‎‡A  The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder.‏ ‎‡9  1‏
919 ‎‡a  3decadesofantidepressantanxiolyticandhypnoticuseinanationalpopulationbirthcohort‏ ‎‡A  Three decades of antidepressant, anxiolytic and hypnotic use in a national population birth cohort‏ ‎‡9  1‏
919 ‎‡a  3yearoutcomeof1episodepsychosesinanestablishedcommunitypsychiatricservice‏ ‎‡A  Three-year outcome of first-episode psychoses in an established community psychiatric service.‏ ‎‡9  1‏
919 ‎‡a  translatingtheepidemiologyofpsychosisintopublicmentalhealthevidencechallengesandfutureprospects‏ ‎‡A  Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects‏ ‎‡9  1‏
919 ‎‡a  traumaexposureptsdandpsychoticlikesymptomsinpostconflicttimorlesteanepidemiologicalsurvey‏ ‎‡A  Trauma exposure, PTSD and psychotic-like symptoms in post-conflict Timor Leste: an epidemiological survey‏ ‎‡9  1‏
919 ‎‡a  traumahistorycharacteristicsassociatedwithmentalstatesatclinicalhighriskforpsychosis‏ ‎‡A  Trauma history characteristics associated with mental states at clinical high risk for psychosis‏ ‎‡9  1‏
919 ‎‡a  unemploymentsocialisolationachievementexpectationmismatchandpsychosisfindingsfromtheaesopstudy‏ ‎‡A  Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study‏ ‎‡9  1‏
919 ‎‡a  useofthetheoryofplannedbehaviourtoassessfactorsinfluencingtheidentificationofindividualsatultrahighriskforpsychosisinprimarycare‏ ‎‡A  Use of the theory of planned behaviour to assess factors influencing the identification of individuals at ultra-high risk for psychosis in primary care‏ ‎‡9  1‏
919 ‎‡a  usefulnessofeq5dforevaluationofhealthrelatedqualityoflifeinyoungadultswith1episodepsychosis‏ ‎‡A  Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis‏ ‎‡9  1‏
919 ‎‡a  verbalfluencyinpatientswithschizophreniaandaffectivepsychosesandtheir1degreerelatives‏ ‎‡A  Verbal fluency in patients with schizophrenia and affective psychoses and their first-degree relatives‏ ‎‡9  1‏
919 ‎‡a  viewsofyoungpeopleinearlyinterventionservicesfor1episodepsychosisinengland‏ ‎‡A  Views of Young People in Early Intervention Services for First-Episode Psychosis in England‏ ‎‡9  1‏
919 ‎‡a  visuospatiallearningandexecutivefunctionareindependentlyimpairedin1episodepsychosis‏ ‎‡A  Visuospatial learning and executive function are independently impaired in first-episode psychosis.‏ ‎‡9  1‏
919 ‎‡a  vitamin500supplementationduringthe1yearoflifeandriskofschizophreniaafinnishbirthcohortstudy‏ ‎‡A  Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study‏ ‎‡9  1‏
919 ‎‡a  volumesofbraingreyandwhitematterandcerebrospinalfluidinschizophreniainthenorthernfinland1966birthcohortanepidemiologicalapproachtoanalysis‏ ‎‡A  Volumes of brain, grey and white matter and cerebrospinal fluid in schizophrenia in the Northern Finland 1966 Birth Cohort: an epidemiological approach to analysis‏ ‎‡9  1‏
919 ‎‡a  warexperiencesgeneralfunctioningandbarrierstocareamongformerchildsoldiersinnorthernugandathewaysstudy‏ ‎‡A  War experiences, general functioning and barriers to care among former child soldiers in Northern Uganda: the WAYS study‏ ‎‡9  1‏
919 ‎‡a  whichcharacteristicsofschizophreniapredatepsychosis‏ ‎‡A  Which characteristics of schizophrenia predate psychosis?‏ ‎‡9  1‏
919 ‎‡a  whitematterstructureinyoungadultswithfamilialriskforpsychosistheoulubrainandmindstudy‏ ‎‡A  White matter structure in young adults with familial risk for psychosis - The Oulu Brain and Mind Study‏ ‎‡9  1‏
919 ‎‡a  whypsychiatrycantaffordtobeneurophobic‏ ‎‡A  Why psychiatry can't afford to be neurophobic‏ ‎‡9  1‏
919 ‎‡a  youngpeopleatriskforpsychosiscasefindingandsamplecharacteristicsoftheoulubrainandmindstudy‏ ‎‡A  Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study‏ ‎‡9  1‏
919 ‎‡a  youngpeoplesviewsofukmentalhealthservices‏ ‎‡A  Young people's views of UK mental health services‏ ‎‡9  1‏
919 ‎‡a  5httlprandearlychildhoodadversitiesmoderatecognitiveandemotionalprocessinginadolescence‏ ‎‡A  5-HTTLPR and early childhood adversities moderate cognitive and emotional processing in adolescence‏ ‎‡9  1‏
919 ‎‡a  classcontrastivehumaninterpretablemachinelearningapproachtopredictmortalityinseverementalillness‏ ‎‡A  A class-contrastive human-interpretable machine learning approach to predict mortality in severe mental illness‏ ‎‡9  1‏
919 ‎‡a  comparisonofclinicalandresearchdsm3rdiagnosesofschizophreniainafinnishnationalbirthcohortclinicalandresearchdiagnosesofschizophrenia‏ ‎‡A  A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia‏ ‎‡9  1‏
919 ‎‡a  computationalanalysisofabnormalbeliefupdatingprocessesandtheirassociationwithpsychoticexperiencesandchildhoodtraumainaukbirthcohort‏ ‎‡A  A Computational Analysis of Abnormal Belief Updating Processes and Their Association With Psychotic Experiences and Childhood Trauma in a UK Birth Cohort‏ ‎‡9  1‏
919 ‎‡a  longitudinaltypologyofsymptomsofdepressionandanxietyoverthelifecourse‏ ‎‡A  A longitudinal typology of symptoms of depression and anxiety over the life course‏ ‎‡9  1‏
919 ‎‡a  populationbasedlongitudinalstudyofchildhoodneurodevelopmentaldisordersiqandsubsequentriskofpsychoticexperiencesinadolescence‏ ‎‡A  A population-based longitudinal study of childhood neurodevelopmental disorders, IQ and subsequent risk of psychotic experiences in adolescence‏ ‎‡9  1‏
919 ‎‡a  populationbasedprospectivebirthcohortstudyofchildhoodneurocognitiveandpsychologicalfunctioninginhealthysurvivorsofearlylifemeningitis‏ ‎‡A  A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis‏ ‎‡9  1‏
919 ‎‡a  populationbasedstudyofatopicdisordersandinflammatorymarkersinchildhoodbeforepsychoticexperiencesinadolescence‏ ‎‡A  A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence‏ ‎‡9  1‏
919 ‎‡a  populationbasedstudyofgeneticvariationandpsychoticexperiencesinadolescents‏ ‎‡A  A population-based study of genetic variation and psychotic experiences in adolescents‏ ‎‡9  1‏
919 ‎‡a  populationlevelpredictiontoolfortheincidenceof1episodepsychosistranslationalepidemiologybasedoncrosssectionaldata‏ ‎‡A  A population-level prediction tool for the incidence of first-episode psychosis: translational epidemiology based on cross-sectional data‏ ‎‡9  1‏
919 ‎‡a  quantitativemetaanalysisofpopulationbasedstudiesofpremorbidintelligenceandschizophrenia‏ ‎‡A  A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia.‏ ‎‡9  1‏
919 ‎‡a  randomizedcontrolledtrialofthecostutilityof2generationantipsychoticsinpeoplewithpsychosisandeligibleforclozapine‏ ‎‡A  A randomized controlled trial of the cost-utility of second-generation antipsychotics in people with psychosis and eligible for clozapine‏ ‎‡9  1‏
919 ‎‡a  abnormalrewardpredictionerrorsignallinginantipsychoticnaiveindividualswith1episodepsychosisorclinicalriskforpsychosis‏ ‎‡A  Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis.‏ ‎‡9  1‏
919 ‎‡a  acuteandtransientpsychoticdisordersprecursorsepidemiologycourseandoutcome‏ ‎‡A  Acute and transient psychotic disorders: precursors, epidemiology, course and outcome.‏ ‎‡9  1‏
919 ‎‡a  administrativeincidenceofpsychosisassessedinanearlyinterventionserviceinengland1epidemiologicalevidencefromadiverseruralandurbansetting‏ ‎‡A  Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting.‏ ‎‡9  1‏
919 ‎‡a  adolescenceisassociatedwithgenomicallypatternedconsolidationofthehubsofthehumanbrainconnectome‏ ‎‡A  Adolescence is associated with genomically patterned consolidation of the hubs of the human brain connectome‏ ‎‡9  1‏
919 ‎‡a  adolescentfriendshipspredictlaterresilientfunctioningacrosspsychosocialdomainsinahealthycommunitycohort‏ ‎‡A  Adolescent friendships predict later resilient functioning across psychosocial domains in a healthy community cohort‏ ‎‡9  1‏
919 ‎‡a  adolescentselfcontrolpredictsmidlifehallucinatoryexperiences40yearfollowupofanationalbirthcohort‏ ‎‡A  Adolescent self-control predicts midlife hallucinatory experiences: 40-year follow-up of a national birth cohort‏ ‎‡9  1‏
919 ‎‡a  adolescentselforganizationpredictsmidlifememoryinaprospectivebirthcohortstudy‏ ‎‡A  Adolescent self-organization predicts midlife memory in a prospective birth cohort study‏ ‎‡9  1‏
919 ‎‡a  aggressivebehaviourat1contactwithservicesfindingsfromtheaesop1episodepsychosisstudy‏ ‎‡A  Aggressive behaviour at first contact with services: findings from the AESOP First Episode Psychosis Study.‏ ‎‡9  1‏
919 ‎‡a  aggressiveincidentsin1episodepsychosis‏ ‎‡A  Aggressive incidents in first-episode psychosis.‏ ‎‡9  1‏
919 ‎‡a  antipsychotictreatmentresistancein1episodepsychosisprevalencesubtypesandpredictors‏ ‎‡A  Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors.‏ ‎‡9  1‏
919 ‎‡a  antipsychotictypeandcorrelatesofantipsychotictreatmentdiscontinuationintheoutpatienttreatmentofschizophrenia‏ ‎‡A  Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophrenia‏ ‎‡9  1‏
919 ‎‡a  appraisalsofstressorsandcommonmentaldisorderfromearlytomidadulthoodinthe1946britishbirthcohort‏ ‎‡A  Appraisals of stressors and common mental disorder from early to mid-adulthood in the 1946 British birth cohort‏ ‎‡9  1‏
919 ‎‡a  assessmentofposttraumaticsymptomsinpatientswith1episodepsychosis‏ ‎‡A  Assessment of posttraumatic symptoms in patients with first-episode psychosis‏ ‎‡9  1‏
919 ‎‡a  assessmentofremissioninschizophreniawiththecgiandcgischscales‏ ‎‡A  Assessment of remission in schizophrenia with the CGI and CGI-SCH scales‏ ‎‡9  1‏
919 ‎‡a  associationbetweencentralnervoussysteminfectionsduringchildhoodandadultonsetschizophreniaandotherpsychosesa28yearfollowup‏ ‎‡A  Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up‏ ‎‡9  1‏
919 ‎‡a  associationbetweencommonearlychildhoodinfectionandsubsequentdepressivesymptomsandpsychoticexperiencesinadolescenceapopulationbasedlongitudinalbirthcohortstudy‏ ‎‡A  Association between common early-childhood infection and subsequent depressive symptoms and psychotic experiences in adolescence: a population-based longitudinal birth cohort study‏ ‎‡9  1‏
919 ‎‡a  associationbetweendevelopmentalmilestonesandageofschizophreniaonsetresultsfromthenorthernfinlandbirthcohort‏ ‎‡A  Association between developmental milestones and age of schizophrenia onset: Results from the Northern Finland Birth Cohort 1966‏ ‎‡9  1‏
919 ‎‡a  associationbetweendurationofuntreatedpsychosisandbrainmorphologyinschizophreniawithinthenorthernfinland1966birthcohort‏ ‎‡A  Association between duration of untreated psychosis and brain morphology in schizophrenia within the Northern Finland 1966 Birth Cohort.‏ ‎‡9  1‏
919 ‎‡a  associationbetweendurationofuntreatedpsychosisandoutcomeincohortsof1episodepatientsasystematicreview‏ ‎‡A  Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review‏ ‎‡9  1‏
919 ‎‡a  associationbetweenserum100reactiveproteinanddsm4generalizedanxietydisorderinadolescencefindingsfromthealspaccohort‏ ‎‡A  Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: Findings from the ALSPAC cohort.‏ ‎‡9  1‏
919 ‎‡a  associationofcannabisusewithprodromalsymptomsofpsychosisinadolescence‏ ‎‡A  Association of cannabis use with prodromal symptoms of psychosis in adolescence‏ ‎‡9  1‏
919 ‎‡a  associationofextentofcannabisuseandpsychoticlikeintoxicationexperiencesinamultinationalsampleof1episodepsychosispatientsandcontrols‏ ‎‡A  Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls‏ ‎‡9  1‏
919 ‎‡a  associationofseruminterleukin6and100reactiveproteininchildhoodwithdepressionandpsychosisinyoungadultlifeapopulationbasedlongitudinalstudy‏ ‎‡A  Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study‏ ‎‡9  1‏
919 ‎‡a  associationsbetweenearlydevelopmentandoutcomeinschizophreniaa35yearfollowupofthenorthernfinland1966birthcohort‏ ‎‡A  Associations between early development and outcome in schizophrenia — A 35-year follow-up of the Northern Finland 1966 Birth Cohort‏ ‎‡9  1‏
919 ‎‡a  authorsreplyrelongitudinaleffectofclozapineassociatedsedationonmotivationinschizophrenianaturalisticlongitudinalstudy‏ ‎‡A  Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study‏ ‎‡9  1‏
919 ‎‡a  autoimmunediseasesinthepedigreesofschizophrenicandcontrolsubjects‏ ‎‡A  Autoimmune diseases in the pedigrees of schizophrenic and control subjects‏ ‎‡9  1‏
919 ‎‡a  bilateralhippocampalincreasefollowing1episodepsychosisisassociatedwithgoodclinicalfunctionalandcognitiveoutcomes‏ ‎‡A  Bilateral hippocampal increase following first-episode psychosis is associated with good clinical, functional and cognitive outcomes‏ ‎‡9  1‏
919 ‎‡a  biologicalandpsychosocialriskfactorsforpsychoticmajordepression‏ ‎‡A  Biological and psychosocial risk factors for psychotic major depression.‏ ‎‡9  1‏
919 ‎‡a  birthcohortstudiesinpsychiatrybeginningatthebeginning‏ ‎‡A  Birth cohort studies in psychiatry: beginning at the beginning‏ ‎‡9  1‏
919 ‎‡a  birthorderandriskforschizophreniaa31yearfollowupofthenorthernfinland1966birthcohort‏ ‎‡A  Birth order and risk for schizophrenia: a 31-year follow-up of the Northern Finland 1966 Birth Cohort‏ ‎‡9  1‏
919 ‎‡a  brainbehaviourmodesofcovariationinhealthyandclinicallydepressedyoungpeople‏ ‎‡A  Brain-behaviour modes of covariation in healthy and clinically depressed young people‏ ‎‡9  1‏
919 ‎‡a  brainmicroarchitectureanddisinhibitionalatentphenotypingstudyacross33impulsiveandcompulsivebehaviours‏ ‎‡A  Brain micro-architecture and disinhibition: a latent phenotyping study across 33 impulsive and compulsive behaviours‏ ‎‡9  1‏
919 ‎‡a  brainstructureindifferentpsychosisriskgroupsinthenorthernfinland1986birthcohort‏ ‎‡A  Brain structure in different psychosis risk groups in the Northern Finland 1986 Birth Cohort‏ ‎‡9  1‏
919 ‎‡a  breakingtheweblifebeyondtheatriskmentalstateforpsychosis‏ ‎‡A  Breaking the web: life beyond the at-risk mental state for psychosis‏ ‎‡9  1‏
919 ‎‡a  cannabisandacutepsychosis‏ ‎‡A  Cannabis and acute psychosis.‏ ‎‡9  1‏
919 ‎‡a  cannabisandschizophreniamodelprojectionsoftheimpactoftheriseincannabisuseonhistoricalandfuturetrendsinschizophreniainenglandandwales‏ ‎‡A  Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales‏ ‎‡9  1‏
919 ‎‡a  cannabisuseandoutcomeofrecentonsetpsychosis‏ ‎‡A  Cannabis use and outcome of recent onset psychosis‏ ‎‡9  1‏
919 ‎‡a  cannabisuseandriskofpsychoticoraffectivementalhealthoutcomesasystematicreview‏ ‎‡A  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review‏ ‎‡9  1‏
919 ‎‡a  cannabisusegenderandageofonsetofschizophreniadatafromtheaesopstudy‏ ‎‡A  Cannabis use, gender and age of onset of schizophrenia: data from the ÆSOP study‏ ‎‡9  1‏
919 ‎‡a  cannabisuseisassociatedwithincreasedccl11plasmalevelsinyounghealthyvolunteers‏ ‎‡A  Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers‏ ‎‡9  1‏
919 ‎‡a  caregivingin1episodepsychosissocialcharacteristicsassociatedwithperceivedburdenandassociationswithcompulsorytreatment‏ ‎‡A  Caregiving in first-episode psychosis: social characteristics associated with perceived ‘burden’ and associations with compulsory treatment‏ ‎‡9  1‏
919 ‎‡a  changesinverballearningandmemoryinschizophreniaandnonpsychoticcontrolsinmidlifea9yearfollowupinthenorthernfinlandbirthcohortstudy‏ ‎‡A  Changes in verbal learning and memory in schizophrenia and non-psychotic controls in midlife: A nine-year follow-up in the Northern Finland Birth Cohort study 1966.‏ ‎‡9  1‏
919 ‎‡a  childdevelopmentriskfactorsforadultschizophreniainthebritish1946birthcohort‏ ‎‡A  Child development risk factors for adult schizophrenia in the British 1946 birth cohort‏ ‎‡9  1‏
919 ‎‡a  childhoodadversitysubtypesanddepressivesymptomsinearlyandlateadolescence‏ ‎‡A  Childhood adversity subtypes and depressive symptoms in early and late adolescence‏ ‎‡9  1‏
919 ‎‡a  childhoodcentralnervoussysteminfectionsandriskforschizophrenia‏ ‎‡A  Childhood central nervous system infections and risk for schizophrenia‏ ‎‡9  1‏
919 ‎‡a  childhoodcognitiveabilityandadultmentalhealthinthebritish1946birthcohort‏ ‎‡A  Childhood cognitive ability and adult mental health in the British 1946 birth cohort‏ ‎‡9  1‏
919 ‎‡a  childhoodcognitivefunctionandadultpsychopathologyassociationswithpsychoticandnonpsychoticsymptomsinthegeneralpopulation‏ ‎‡A  Childhood cognitive function and adult psychopathology: associations with psychotic and non-psychotic symptoms in the general population‏ ‎‡9  1‏
919 ‎‡a  childhoodepsteinbarrvirusinfectionandsubsequentriskofpsychoticexperiencesinadolescenceapopulationbasedprospectiveserologicalstudy‏ ‎‡A  Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study‏ ‎‡9  1‏
919 ‎‡a  childhoodinfectionandadultschizophreniaametaanalysisofpopulationbasedstudies‏ ‎‡A  Childhood infection and adult schizophrenia: a meta-analysis of population-based studies‏ ‎‡9  1‏
919 ‎‡a  childhoodlateralityandlaterriskofschizophreniainthe1946britishbirthcohort‏ ‎‡A  Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort‏ ‎‡9  1‏
919 ‎‡a  childhoodschizotypyandpositivesymptomsinschizophrenicpatientspredictschizotypyinrelatives‏ ‎‡A  Childhood schizotypy and positive symptoms in schizophrenic patients predict schizotypy in relatives‏ ‎‡9  1‏
919 ‎‡a  childhoodtraumaandcognitivefunctionin1episodeaffectiveandnonaffectivepsychosis‏ ‎‡A  Childhood trauma and cognitive function in first-episode affective and non-affective psychosis‏ ‎‡9  1‏
919 ‎‡a  clinicalandsocialdeterminantsofdurationofuntreatedpsychosisintheaesop1episodepsychosisstudy‏ ‎‡A  Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study.‏ ‎‡9  1‏
919 ‎‡a  clinicalandsociodemographiccomparisonofpeopleathighriskforpsychosisandwith1episodepsychosis‏ ‎‡A  Clinical and sociodemographic comparison of people at high-risk for psychosis and with first-episode psychosis‏ ‎‡9  1‏
919 ‎‡a  cognitivebehaviourtherapyforimprovingsocialrecoveryinpsychosiscosteffectivenessanalysis‏ ‎‡A  Cognitive behaviour therapy for improving social recovery in psychosis: Cost-effectiveness analysis‏ ‎‡9  1‏
919 ‎‡a  cognitiveeffectsofgeneticvariationinmonoamineneurotransmittersystemsapopulationbasedstudyofcomtmaoaand5httlpr‏ ‎‡A  Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR.‏ ‎‡9  1‏
919 ‎‡a  cognitivereserveinneuropsychiatry‏ ‎‡A  Cognitive reserve in neuropsychiatry.‏ ‎‡9  1‏
919 ‎‡a  cohortprofilementalhealthfollowingextremetraumainanorthernugandancohortofwaraffectedyouthstudy‏ ‎‡A  Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study‏ ‎‡9  1‏
919 ‎‡a  cohortprofilementalhealthfollowingextremetraumainanorthernugandancohortofwaraffectedyouthstudythewaysstudy‏ ‎‡A  Cohort profile: mental health following extreme trauma in a northern Ugandan cohort of War-Affected Youth Study (The WAYS Study).‏ ‎‡9  1‏
919 ‎‡a  cohortprofileriskpatternsandprocessesforpsychopathologyemergingduringadolescencetherootsproject‏ ‎‡A  Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project‏ ‎‡9  1‏
919 ‎‡a  combiningdimensionalandcategoricalrepresentationofpsychosisthewayforwardfordsm5andicd11‏ ‎‡A  Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?‏ ‎‡9  1‏
919 ‎‡a  commonversuspsychopathologyspecificriskfactorsforpsychoticexperiencesanddepressionduringadolescence‏ ‎‡A  Common versus psychopathology-specific risk factors for psychotic experiences and depression during adolescence‏ ‎‡9  1‏
919 ‎‡a  comparativeeffectivenessofcognitivetherapiesdeliveredfacetofaceoroverthetelephoneanobservationalstudyusingpropensitymethods‏ ‎‡A  Comparative effectiveness of cognitive therapies delivered face-to-face or over the telephone: an observational study using propensity methods‏ ‎‡9  1‏
919 ‎‡a  comparingtimeuseinindividualsatdifferentstagesofpsychosisandanonclinicalcomparisongroup‏ ‎‡A  Comparing time use in individuals at different stages of psychosis and a non-clinical comparison group‏ ‎‡9  1‏
919 ‎‡a  comparisonofhighandlowintensitycontactbetweensecondaryandprimarycaretodetectpeopleatultrahighriskforpsychosisstudyprotocolforatheorybasedclusterrandomizedcontrolledtrial‏ ‎‡A  Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial‏ ‎‡9  1‏
919 ‎‡a  compulsivityandimpulsivitytraitslinkedtoattenuateddevelopmentalfrontostriatalmyelinationtrajectories‏ ‎‡A  Compulsivity and impulsivity traits linked to attenuated developmental frontostriatal myelination trajectories‏ ‎‡9  1‏
919 ‎‡a  correctionsharedmechanismsbetweencoronaryheartdiseaseanddepressionfindingsfromalargeukgeneralpopulationbasedcohort‏ ‎‡A  Correction: Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort‏ ‎‡9  1‏
919 ‎‡a  costeffectivenessof152generationantipsychoticdrugsresultsfromarandomisedcontrolledtrialinschizophreniarespondingpoorlytoprevioustherapy‏ ‎‡A  Cost-effectiveness of first- v. second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy.‏ ‎‡9  1‏
919 ‎‡a  costofimprovingaccesstopsychologicaltherapiesiaptprogrammeananalysisofcostofsessiontreatmentandrecoveryinselectedprimarycaretrustsintheeastofenglandregion‏ ‎‡A  Cost of improving Access to Psychological Therapies (IAPT) programme: an analysis of cost of session, treatment and recovery in selected Primary Care Trusts in the East of England region‏ ‎‡9  1‏
919 ‎‡a  criminaloffendinganddistinguishingfeaturesofoffendersamongpersonsexperiencinga1episodeofpsychosis‏ ‎‡A  Criminal offending and distinguishing features of offenders among persons experiencing a first episode of psychosis‏ ‎‡9  1‏
919 ‎‡a  crossnationalclinicalandfunctionalremissionratesworldwideschizophreniaoutpatienthealthoutcomes‏ ‎‡A  Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes‏ ‎‡9  1‏
919 ‎‡a  crossnationalclinicalandfunctionalremissionratesworldwideschizophreniaoutpatienthealthoutcomeswsohostudy‏ ‎‡A  Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study‏ ‎‡9  1‏
919 ‎‡a  culturaldifferencesinpathwaystocareserviceuseandtreatedoutcomes‏ ‎‡A  Cultural differences in pathways to care, service use and treated outcomes‏ ‎‡9  1‏
919 ‎‡a  cumulativesocialdisadvantageethnicityand1episodepsychosisacasecontrolstudy‏ ‎‡A  Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study‏ ‎‡9  1‏
919 ‎‡a  dailyuseofhighpotencycannabisisassociatedwithmorepositivesymptomsin1episodepsychosispatientstheeugeicasecontrolstudy‏ ‎‡A  Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study‏ ‎‡9  1‏
919 ‎‡a  defaultmodenetworkinyoungpeoplewithfamilialriskforpsychosistheoulubrainandmindstudy‏ ‎‡A  Default mode network in young people with familial risk for psychosis--the Oulu Brain and Mind study‏ ‎‡9  1‏
919 ‎‡a  definingtheneedsofpatientswithintellectualdisabilitiesinthehighsecuritypsychiatrichospitalsinengland‏ ‎‡A  Defining the needs of patients with intellectual disabilities in the high security psychiatric hospitals in England.‏ ‎‡9  1‏
919 ‎‡a  depressivesymptomsduringadolescencecomparisonbetweenepidemiologicalandhighrisksampling‏ ‎‡A  Depressive symptoms during adolescence: comparison between epidemiological and high risk sampling‏ ‎‡9  1‏
919 ‎‡a  determiningthechronologyandcomponentsofpsychosisonsetthenottinghamonsetschedule‏ ‎‡A  Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule‏ ‎‡9  1‏
919 ‎‡a  determiningthechronologyandcomponentsofpsychosisonsetthenottinghamonsetschedulenos‏ ‎‡A  Determining the chronology and components of psychosis onset: The Nottingham Onset Schedule (NOS).‏ ‎‡9  1‏
919 ‎‡a  developmentalcognitiveneuroscienceusinglatentchangescoremodelsatutorialandapplications‏ ‎‡A  Developmental cognitive neuroscience using latent change score models: A tutorial and applications.‏ ‎‡9  1‏
919 ‎‡a  developmentaltypologyoftrajectoriestonighttimebladdercontrolepidemiologicapplicationoflongitudinallatentclassanalysis‏ ‎‡A  Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis‏ ‎‡9  1‏
919 ‎‡a  deviantintrauterinegrowthandriskofschizophreniaa34yearfollowupofthenorthernfinland1966birthcohort‏ ‎‡A  Deviant intrauterine growth and risk of schizophrenia: a 34-year follow-up of the Northern Finland 1966 Birth Cohort‏ ‎‡9  1‏
919 ‎‡a  diagnosticchange10yearsaftera1episodeofpsychosis‏ ‎‡A  Diagnostic change 10 years after a first episode of psychosis‏ ‎‡9  1‏
919 ‎‡a  diagnosticstabilityandoutcomeafter1episodepsychosis‏ ‎‡A  Diagnostic stability and outcome after first episode psychosis‏ ‎‡9  1‏
919 ‎‡a  differenteffectsoftypicalandatypicalantipsychoticsongreymatterin1episodepsychosistheaesopstudy‏ ‎‡A  Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study‏ ‎‡9  1‏
919 ‎‡a  differentvulnerabilityindicatorsforpsychosisandtheirneuropsychologicalcharacteristicsinthenorthernfinland1986birthcohort‏ ‎‡A  Different vulnerability indicators for psychosis and their neuropsychological characteristics in the Northern Finland 1986 Birth Cohort‏ ‎‡9  1‏
919 ‎‡a  differentialrelationshipbetweenneurologicalandcognitivedysfunctionin1episodepsychosispatientsandinhealthyindividuals‏ ‎‡A  Differential relationship between neurological and cognitive dysfunction in first episode psychosis patients and in healthy individuals‏ ‎‡9  1‏
919 ‎‡a  differingpatternsofbrainstructuralabnormalitiesbetweenblackandwhitepatientswiththeir1episodeofpsychosis‏ ‎‡A  Differing patterns of brain structural abnormalities between black and white patients with their first episode of psychosis‏ ‎‡9  1‏
919 ‎‡a  dischargedfromspecialhospitalunderrestrictionsacomparisonofthefatesofpsychopathsandthementallyill‏ ‎‡A  Discharged from special hospital under restrictions: a comparison of the fates of psychopaths and the mentally ill‏ ‎‡9  1‏
919 ‎‡a  diseaserelevantautoantibodiesin1episodeschizophrenia‏ ‎‡A  Disease-relevant autoantibodies in first episode schizophrenia‏ ‎‡9  1‏
919 ‎‡a  doobstetriccomplicationscausetheearlierageatonsetinmalethanfemaleschizophrenics‏ ‎‡A  Do obstetric complications cause the earlier age at onset in male than female schizophrenics?‏ ‎‡9  1‏
919 ‎‡a  doesmaternalbodymassindexduringpregnancyinfluenceriskofschizophreniaintheadultoffspring‏ ‎‡A  Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring?‏ ‎‡9  1‏
919 ‎‡a  durationofprodromalphaseandseverityofvolumetricabnormalitiesin1episodepsychosis‏ ‎‡A  Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis‏ ‎‡9  1‏
919 ‎‡a  durationofuntreatedpsychosisandethnicityintheaesop1onsetpsychosisstudy‏ ‎‡A  Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study‏ ‎‡9  1‏
919 ‎‡a  durationofuntreatedpsychosisandneuropsychologicalfunctionin1episodepsychosis‏ ‎‡A  Duration of untreated psychosis and neuropsychological function in first episode psychosis.‏ ‎‡9  1‏
919 ‎‡a  earlydetectionandinterventionevaluationforpeopleathighriskofpsychosis2edie2trialrationaledesignandbaselinecharacteristics‏ ‎‡A  Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristics.‏ ‎‡9  1‏
919 ‎‡a  earlydetectionandinterventionevaluationforpeopleatriskofpsychosismultisiterandomisedcontrolledtrial‏ ‎‡A  Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial.‏ ‎‡9  1‏
919 ‎‡a  earlydevelopmentstressanddepressionacrossthelifecoursepathwaystodepressioninanationalbritishbirthcohort‏ ‎‡A  Early development, stress and depression across the life course: pathways to depression in a national British birth cohort‏ ‎‡9  1‏
919 ‎‡a  earlyinterventionforincipientinsanityearlynotionsfromthe19thcenturyenglishliterature‏ ‎‡A  Early intervention for incipient insanity: early notions from the 19(th) century English literature.‏ ‎‡9  1‏
919 ‎‡a  earlyinterventioninpsychosiskeepingthebodyinmind‏ ‎‡A  Early intervention in psychosis: keeping the body in mind‏ ‎‡9  1‏
919 ‎‡a  earlyinterventionservicesinpsychosisfromevidencetowideimplementation‏ ‎‡A  Early intervention services in psychosis: from evidence to wide implementation.‏ ‎‡9  1‏
919 ‎‡a  earlyriskfactorsandadultpersonenvironmentrelationshipsinaffectivedisorder‏ ‎‡A  Early risk factors and adult person--environment relationships in affective disorder.‏ ‎‡9  1‏
919 ‎‡a  earlyriskfactorsforsuicideinanepidemiological1episodepsychosiscohort‏ ‎‡A  Early risk factors for suicide in an epidemiological first episode psychosis cohort‏ ‎‡9  1‏
919 ‎‡a  earlysustainedrecoveryfollowing1episodepsychosisevidencefromtheaesop10followupstudy‏ ‎‡A  Early sustained recovery following first episode psychosis: Evidence from the AESOP10 follow-up study.‏ ‎‡9  1‏
919 ‎‡a  educationalconsequencesofmentaldisorderstreatedinhospitala31yearfollowupofthenorthernfinland1966birthcohort‏ ‎‡A  Educational consequences of mental disorders treated in hospital. A 31-year follow-up of the Northern Finland 1966 Birth Cohort.‏ ‎‡9  1‏
919 ‎‡a  effectofdelayingtreatmentof1episodepsychosisonsymptomsandsocialoutcomesalongitudinalanalysisandmodellingstudy‏ ‎‡A  Effect of delaying treatment of first-episode psychosis on symptoms and social outcomes: a longitudinal analysis and modelling study‏ ‎‡9  1‏
919 ‎‡a  effectofpriortreatmentwithantipsychoticlongactinginjectiononrandomisedclinicaltrialtreatmentoutcomes‏ ‎‡A  Effect of prior treatment with antipsychotic long-acting injection on randomised clinical trial treatment outcomes‏ ‎‡9  1‏
919 ‎‡a  effectivenessofantipsychotictreatmentforschizophrenia6monthresultsofthepaneuropeanschizophreniaoutpatienthealthoutcomes‏ ‎‡A  Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes‏ ‎‡9  1‏
919 ‎‡a  effectivenessofantipsychotictreatmentforschizophrenia6monthresultsofthepaneuropeanschizophreniaoutpatienthealthoutcomessohostudy‏ ‎‡A  Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study‏ ‎‡9  1‏
919 ‎‡a  effectsofcannabisuseonoutcomesofpsychoticdisorderssystematicreview‏ ‎‡A  Effects of cannabis use on outcomes of psychotic disorders: systematic review‏ ‎‡9  1‏
919 ‎‡a  effectsofcatecholomethyltransferaseonnormalvariationinthecognitivefunctionofchildren‏ ‎‡A  Effects of catechol-O-methyltransferase on normal variation in the cognitive function of children‏ ‎‡9  1‏
919 ‎‡a  effectsofmodafiniloncognitivefunctionsin1episodepsychosis‏ ‎‡A  Effects of modafinil on cognitive functions in first episode psychosis‏ ‎‡9  1‏
919 ‎‡a  effectsofmodafinilonemotionalprocessingin1episodepsychosis‏ ‎‡A  Effects of modafinil on emotional processing in first episode psychosis‏ ‎‡9  1‏
919 ‎‡a  effectsofthecatecholomethyltransferaseval158metpolymorphismonexecutivefunctionametaanalysisofthewisconsincardsorttestinschizophreniaandhealthycontrols‏ ‎‡A  Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls‏ ‎‡9  1‏
919 ‎‡a  elevatedmorningcortisolisastratifiedpopulationlevelbiomarkerformajordepressioninboysonlywithhighdepressivesymptoms‏ ‎‡A  Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms‏ ‎‡9  1‏
919 ‎‡a  epidemiologicalaspectsofmigrationandmentalillness‏ ‎‡A  Epidemiological aspects of migration and mental illness‏ ‎‡9  1‏
919 ‎‡a  epidemiologicalchallengesinsystematicreviews‏ ‎‡A  Epidemiological challenges in systematic reviews‏ ‎‡9  1‏
919 ‎‡a  establishingatheorybasedmultilevelapproachforprimarypreventionofmentaldisordersinyoungpeople‏ ‎‡A  Establishing a Theory-Based Multi-Level Approach for Primary Prevention of Mental Disorders in Young People‏ ‎‡9  1‏
919 ‎‡a  ethnicidentityperceptionsofdisadvantageandpsychosisfindingsfromtheaesopstudy‏ ‎‡A  Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study‏ ‎‡9  1‏
919 ‎‡a  ethnicityandmentalhealththeexampleofschizophreniaandrelatedpsychosesinmigrantpopulationsinthewesternworld‏ ‎‡A  Ethnicity and mental health: the example of schizophrenia and related psychoses in migrant populations in the Western world‏ ‎‡9  1‏
919 ‎‡a  ethnicityandmentalhealththeexampleofschizophreniainmigrantpopulationsacrosseurope‏ ‎‡A  Ethnicity and mental health: the example of schizophrenia in migrant populations across Europe‏ ‎‡9  1‏
919 ‎‡a  ethnicityandmentalhealththeexampleofschizophreniaintheafricancaribbeanpopulationineurope‏ ‎‡A  Ethnicity and Mental Health: The Example of Schizophrenia in the African-Caribbean Population in Europe‏ ‎‡9  1‏
919 ‎‡a  ethnicitysocialdisadvantageandpsychoticlikeexperiencesinahealthypopulationbasedsample‏ ‎‡A  Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample‏ ‎‡9  1‏
919 ‎‡a  examiningevidenceforneighbourhoodvariationinthedurationofuntreatedpsychosis‏ ‎‡A  Examining evidence for neighbourhood variation in the duration of untreated psychosis.‏ ‎‡9  1‏
919 ‎‡a  examiningpathwaysbetweengeneticliabilityforschizophreniaandpatternsoftobaccoandcannabisuseinadolescence‏ ‎‡A  Examining pathways between genetic liability for schizophrenia and patterns of tobacco and cannabis use in adolescence‏ ‎‡9  1‏
919 ‎‡a  exerciseanddepressivesymptomsinadolescentsalongitudinalcohortstudy‏ ‎‡A  Exercise and depressive symptoms in adolescents: a longitudinal cohort study‏ ‎‡9  1‏
919 ‎‡a  explainingsexdifferencesincourseandoutcomeinthefunctionalpsychoses‏ ‎‡A  Explaining sex differences in course and outcome in the functional psychoses‏ ‎‡9  1‏
919 ‎‡a  expressedemotionrelevancetorehospitalizationinschizophreniaover7years‏ ‎‡A  Expressed emotion: relevance to rehospitalization in schizophrenia over 7 years‏ ‎‡9  1‏
919 ‎‡a  extrapyramidalmotorsideeffectsof1and2generationantipsychoticdrugs‏ ‎‡A  Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs‏ ‎‡9  1‏
919 ‎‡a  factorsassociatedwithantidepressantanxiolyticandhypnoticuseover17yearsinanationalcohort‏ ‎‡A  Factors associated with antidepressant, anxiolytic and hypnotic use over 17 years in a national cohort‏ ‎‡9  1‏
919 ‎‡a  familyhistoryofautoimmunediseasesinpsychosis‏ ‎‡A  Family history of autoimmune diseases in psychosis‏ ‎‡9  1‏
919 ‎‡a  1vs2generationantipsychoticdrugsinschizophreniareply‏ ‎‡A  First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply‏ ‎‡9  1‏
919 ‎‡a  fortyyearpsychiatricoutcomesfollowingassessmentforinternalizingdisorderinadolescence‏ ‎‡A  Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence.‏ ‎‡9  1‏
919 ‎‡a  friendshipsandfamilysupportreducesubsequentdepressivesymptomsinatriskadolescents‏ ‎‡A  Friendships and Family Support Reduce Subsequent Depressive Symptoms in At-Risk Adolescents‏ ‎‡9  1‏
919 ‎‡a  frontocerebellarsystemsareassociatedwithinfantmotorandadultexecutivefunctionsinhealthyadultsbutnotinschizophrenia‏ ‎‡A  Fronto-cerebellar systems are associated with infant motor and adult executive functions in healthy adults but not in schizophrenia‏ ‎‡9  1‏
919 ‎‡a  functionaldysconnectivityofcorticostriatalcircuitryasariskphenotypeforpsychosis‏ ‎‡A  Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis‏ ‎‡9  1‏
919 ‎‡a  functionalmappingofdynamichappyandfearfulfacialexpressionsinyoungadultswithfamilialriskforpsychosisoulubrainandmindstudy‏ ‎‡A  Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study‏ ‎‡9  1‏
919 ‎‡a  genderdifferencesinincidenceandageatonsetofmaniaandbipolardisorderovera35yearperiodincamberwellengland‏ ‎‡A  Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England.‏ ‎‡9  1‏
919 ‎‡a  genderdifferencesinneuropsychologicalperformanceacrosspsychoticdisordersamulticentrepopulationbasedcasecontrolstudy‏ ‎‡A  Gender differences in neuropsychological performance across psychotic disorders--a multi-centre population based case-control study‏ ‎‡9  1‏
919 ‎‡a  genderdifferencesintheassociationbetweenchildhoodabuseandpsychosis‏ ‎‡A  Gender differences in the association between childhood abuse and psychosis.‏ ‎‡9  1‏
919 ‎‡a  genderdifferencesintheassociationbetweenchildhoodphysicalandsexualabusesocialsupportandpsychosis‏ ‎‡A  Gender differences in the association between childhood physical and sexual abuse, social support and psychosis‏ ‎‡9  1‏
919 ‎‡a  genderspecificeffectsofthecatecholomethyltransferaseval108158metpolymorphismoncognitivefunctioninchildren‏ ‎‡A  Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children‏ ‎‡9  1‏
919 ‎‡a  geneexpressionanalysisinschizophreniareproducibleupregulationofseveralmembersoftheapolipoprotein50familylocatedinahighsusceptibilitylocusforschizophreniaonchromosome22‏ ‎‡A  Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22.‏ ‎‡9  1‏
919 ‎‡a  generaldistresshopelessnesssuicidalideationandworryinginadolescenceconcurrentandpredictivevalidityofasymptomlevelbifactormodelforclinicaldiagnoses‏ ‎‡A  General distress, hopelessness-suicidal ideation and worrying in adolescence: concurrent and predictive validity of a symptom-level bifactor model for clinical diagnoses.‏ ‎‡9  1‏
919 ‎‡a  genesandthesocialenvironment‏ ‎‡A  Genes and the social environment‏ ‎‡9  1‏
919 ‎‡a  genesvirusesandneurodevelopmentalschizophrenia‏ ‎‡A  Genes, viruses and neurodevelopmental schizophrenia‏ ‎‡9  1‏
919 ‎‡a  globalpopulationattributablefractionofpotentiallymodifiableriskfactorsformentaldisordersametaumbrellasystematicreview‏ ‎‡A  Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review‏ ‎‡9  1‏
919 ‎‡a  graymatterabnormalitiesassociatedwithdurationofuntreatedpsychosis‏ ‎‡A  Gray matter abnormalities associated with duration of untreated psychosis‏ ‎‡9  1‏
919 ‎‡a  greymatterabnormalitiesin1episodeschizophreniaandaffectivepsychosis‏ ‎‡A  Grey matter abnormalities in first-episode schizophrenia and affective psychosis‏ ‎‡9  1‏
919 ‎‡a  greymattercorrelatesofminorphysicalanomaliesintheaesop1episodepsychosisstudy‏ ‎‡A  Grey matter correlates of minor physical anomalies in the AeSOP first-episode psychosis study‏ ‎‡9  1‏
919 ‎‡a  heterogeneityinincidenceratesofschizophreniaandotherpsychoticsyndromes‏ ‎‡A  Heterogeneity in Incidence Rates of Schizophrenia and Other Psychotic Syndromes‏ ‎‡9  1‏
919 ‎‡a  hippocampusandamygdalavolumesinschizophreniaandotherpsychosesinthenorthernfinland1966birthcohort‏ ‎‡A  Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort‏ ‎‡9  1‏
919 ‎‡a  ifcannabiscausedschizophreniahowmanycannabisusersmayneedtobepreventedinordertoprevent1caseofschizophreniaenglandandwalescalculations‏ ‎‡A  If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations‏ ‎‡9  1‏
919 ‎‡a  illicitsubstanceuseanditscorrelatesin1episodepsychosis‏ ‎‡A  Illicit substance use and its correlates in first episode psychosis‏ ‎‡9  1‏
919 ‎‡a  immunedysregulationamongstudentsexposedtoexamstressanditsmitigationbymindfulnesstrainingfindingsfromanexploratoryrandomisedtrial‏ ‎‡A  Immune dysregulation among students exposed to exam stress and its mitigation by mindfulness training: findings from an exploratory randomised trial‏ ‎‡9  1‏
919 ‎‡a  immunotherapyforpatientswithacutepsychosisandserumnmethyl500aspartatereceptornmdarantibodiesadescriptionofatreatedcaseseries‏ ‎‡A  Immunotherapy for patients with acute psychosis and serum N-Methyl D-Aspartate receptor (NMDAR) antibodies: a description of a treated case series‏ ‎‡9  1‏
919 ‎‡a  impactofcognitivetherapyoninternalisedstigmainpeoplewithatriskmentalstates‏ ‎‡A  Impact of cognitive therapy on internalised stigma in people with at-risk mental states‏ ‎‡9  1‏
919 ‎‡a  impactofearlyinterventionservicesondurationofuntreatedpsychosisdatafromthenationaledenprospectivecohortstudy‏ ‎‡A  Impact of early intervention services on duration of untreated psychosis: data from the National EDEN prospective cohort study‏ ‎‡9  1‏
919 ‎‡a  improvedqualityoflifeover1yearisassociatedwithimprovedadherenceinpatientswithschizophrenia‏ ‎‡A  Improved quality of life over one year is associated with improved adherence in patients with schizophrenia.‏ ‎‡9  1‏
919 ‎‡a  improvementanddeclineofcognitivefunctioninschizophreniaover1yearalongitudinalinvestigationusinglatentgrowthmodelling‏ ‎‡A  Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling‏ ‎‡9  1‏
919 ‎‡a  improvingaccesstopsychologicaltherapiesandolderpeoplefindingsfromtheeasternregion‏ ‎‡A  Improving access to psychological therapies and older people: findings from the Eastern Region‏ ‎‡9  1‏
919 ‎‡a  incentivemotivationin1episodepsychosisabehaviouralstudy‏ ‎‡A  Incentive motivation in first-episode psychosis: a behavioural study‏ ‎‡9  1‏
919 ‎‡a  incidenceanddistributionof1episodemaniabyageresultsfroma35yearstudy‏ ‎‡A  Incidence and distribution of first-episode mania by age: results from a 35-year study.‏ ‎‡9  1‏
919 ‎‡a  incidenceofbipolaraffectivedisorderin3ukcitiesresultsfromtheaesopstudy‏ ‎‡A  Incidence of bipolar affective disorder in three UK cities: results from the AESOP study.‏ ‎‡9  1‏
919 ‎‡a  incidenceofschizophreniaandotherpsychosesinengland19502009asystematicreviewandmetaanalyses‏ ‎‡A  Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses‏ ‎‡9  1‏
919 ‎‡a  incidenceofschizophreniaandotherpsychosesinethnicminoritygroupsresultsfromthemrcaesopstudy‏ ‎‡A  Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study‏ ‎‡9  1‏
919 ‎‡a  increasedincidenceofpsychoticdisordersinmigrantsfromthecaribbeantotheunitedkingdom‏ ‎‡A  Increased incidence of psychotic disorders in migrants from the Caribbean to the United Kingdom.‏ ‎‡9  1‏
919 ‎‡a  increasedpituitaryvolumeinantipsychoticfreeandantipsychotictreatedpatientsoftheaesop1onsetpsychosisstudy‏ ‎‡A  Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study‏ ‎‡9  1‏
919 ‎‡a  increasedriskofschizophreniafromadditiveinteractionbetweeninfantmotordevelopmentaldelayandobstetriccomplicationsevidencefromapopulationbasedlongitudinalstudy‏ ‎‡A  Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study‏ ‎‡9  1‏
919 ‎‡a  individualizedpredictionofillnesscourseatthe1psychoticepisodeasupportvectormachinemristudy‏ ‎‡A  Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study‏ ‎‡9  1‏
919 ‎‡a  infantdevelopmentalmilestonesandsubsequentcognitivefunction‏ ‎‡A  Infant developmental milestones and subsequent cognitive function‏ ‎‡9  1‏
919 ‎‡a  infantmotordevelopmentandadultcognitivefunctionsinschizophrenia‏ ‎‡A  Infant motor development and adult cognitive functions in schizophrenia.‏ ‎‡9  1‏
919 ‎‡a  infantmotordevelopmentisassociatedwithadultcognitivecategorisationinalongitudinalbirthcohortstudy‏ ‎‡A  Infant motor development is associated with adult cognitive categorisation in a longitudinal birth cohort study.‏ ‎‡9  1‏
919 ‎‡a  inflammationandimmunityinschizophreniaimplicationsforpathophysiologyandtreatment‏ ‎‡A  Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment‏ ‎‡9  1‏
919 ‎‡a  insightgreymatterandcognitivefunctionin1onsetpsychosis‏ ‎‡A  Insight, grey matter and cognitive function in first-onset psychosis‏ ‎‡9  1‏
919 ‎‡a  interactionbetweenparentalpsychosisandearlymotordevelopmentandtheriskofschizophreniainageneralpopulationbirthcohort‏ ‎‡A  Interaction between parental psychosis and early motor development and the risk of schizophrenia in a general population birth cohort‏ ‎‡9  1‏
919 ‎‡a  interplaybetweenchildhoodphysicalabuseandfamilialriskintheonsetofpsychoticdisorders‏ ‎‡A  Interplay between childhood physical abuse and familial risk in the onset of psychotic disorders‏ ‎‡9  1‏
919 ‎‡a  intrinsiccurvatureamarkerofmillimeterscaletangentialcorticocorticalconnectivity‏ ‎‡A  Intrinsic curvature: a marker of millimeter-scale tangential cortico-cortical connectivity?‏ ‎‡9  1‏
919 ‎‡a  investigatingthegeneticarchitectureofgeneralandspecificpsychopathologyinadolescence‏ ‎‡A  Investigating the genetic architecture of general and specific psychopathology in adolescence‏ ‎‡9  1‏
919 ‎‡a  iqinchildhoodpsychiatricattendeespredictsoutcomeoflaterschizophreniaat21yearfollowup‏ ‎‡A  IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up.‏ ‎‡9  1‏
919 ‎‡a  isprematurityassociatedwithadultcognitiveoutcomeandbrainstructure‏ ‎‡A  Is prematurity associated with adult cognitive outcome and brain structure?‏ ‎‡9  1‏
919 ‎‡a  istheincidenceofpsychoticdisorderindeclineepidemiologicalevidencefrom2decadesofresearch‏ ‎‡A  Is the incidence of psychotic disorder in decline? Epidemiological evidence from two decades of research‏ ‎‡9  1‏
919 ‎‡a  istherealinkbetweenchildhoodtraumacognitionandamygdalaandhippocampusvolumein1episodepsychosis‏ ‎‡A  Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis?‏ ‎‡9  1‏
919 ‎‡a  jumpingtoconclusionsgeneralintelligenceandpsychosisliabilityfindingsfromthemulticentriceugeicasecontrolstudy‏ ‎‡A  Jumping To Conclusions, General Intelligence, And Psychosis Liability: Findings From The Multicentric EU-GEI Case-Control Study‏ ‎‡9  1‏
919 ‎‡a  lifeeventsbeforepsychoticepisodesdoclinicalandsocialvariablesaffecttherelationship‏ ‎‡A  Life events before psychotic episodes: do clinical and social variables affect the relationship?‏ ‎‡9  1‏
919 ‎‡a  lifemappingatherapeuticdocumentapproachtoneedsassessment‏ ‎‡A  Life mapping: a 'Therapeutic Document' approach to needs assessment‏ ‎‡9  1‏
919 ‎‡a  lifetimeaffectandmidlifecognitivefunctionprospectivebirthcohortstudy‏ ‎‡A  Lifetime affect and midlife cognitive function: prospective birth cohort study‏ ‎‡9  1‏
919 ‎‡a  lifetimeuseofantipsychoticmedicationanditsrelationtochangeofverballearningandmemoryinmidlifeschizophreniaanobservational9yearfollowupstudy‏ ‎‡A  Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia - An observational 9-year follow-up study‏ ‎‡9  1‏
919 ‎‡a  lifetimeuseofpsychiatricmedicationsandcognitionat43yearsofageinschizophreniainthenorthernfinlandbirthcohort‏ ‎‡A  Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.‏ ‎‡9  1‏
919 ‎‡a  linearandnonlinearassociationsofsymptomdimensionsandcognitivefunctionin1onsetpsychosis‏ ‎‡A  Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis‏ ‎‡9  1‏
919 ‎‡a  linkingthedevelopmentalanddegenerativetheoriesofschizophreniaassociationbetweeninfantdevelopmentandadultcognitivedecline‏ ‎‡A  Linking the developmental and degenerative theories of schizophrenia: association between infant development and adult cognitive decline‏ ‎‡9  1‏
919 ‎‡a  linksbetweencreativityandmentaldisorder‏ ‎‡A  Links between creativity and mental disorder‏ ‎‡9  1‏
919 ‎‡a  lithiuminbipolarandotheraffectivedisordersprescribingpracticeintheuk‏ ‎‡A  Lithium in bipolar and other affective disorders: prescribing practice in the UK.‏ ‎‡9  1‏
919 ‎‡a  lithiumismoreeffectivethanplaceboforpreventingallrelapsesinpatientswithbipolarbutnotunipolardisorder‏ ‎‡A  Lithium is more effective than placebo for preventing all relapses in patients with bipolar but not unipolar disorder‏ ‎‡9  1‏
919 ‎‡a  longitudinalassociationsbetweenchildhoodandadulthoodexternalizingandinternalizingpsychopathologyandadolescentsubstanceuse‏ ‎‡A  Longitudinal associations between childhood and adulthood externalizing and internalizing psychopathology and adolescent substance use.‏ ‎‡9  1‏
919 ‎‡a  longitudinalchangesintotalbrainvolumeinschizophreniarelationtosymptomseveritycognitionandantipsychoticmedication‏ ‎‡A  Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication‏ ‎‡9  1‏
919 ‎‡a  longitudinalpopulationsubgroupsofcrpandriskofdepressioninthealspacbirthcohort‏ ‎‡A  Longitudinal population subgroups of CRP and risk of depression in the ALSPAC birth cohort‏ ‎‡9  1‏
919 ‎‡a  longitudinalregionalbrainvolumelossinschizophreniarelationshiptoantipsychoticmedicationandchangeinsocialfunction‏ ‎‡A  Longitudinal regional brain volume loss in schizophrenia: Relationship to antipsychotic medication and change in social function‏ ‎‡9  1‏
919 ‎‡a  lowerprevalenceofpremorbidneurologicalillnessinafricancaribbeanthanwhitepsychoticpatientsinengland‏ ‎‡A  Lower prevalence of pre-morbid neurological illness in African-Caribbean than White psychotic patients in England.‏ ‎‡9  1‏
919 ‎‡a  maternalseparationatbirthandschizophreniaalongtermfollowupofthefinnishchristmassealhomechildren‏ ‎‡A  Maternal separation at birth and schizophrenia—a long-term follow-up of the Finnish Christmas Seal Home Children‏ ‎‡9  1‏
919 ‎‡a  measuringthebenefitsoftreatmentforpsychosisvalidityandresponsivenessoftheeq5d‏ ‎‡A  Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D.‏ ‎‡9  1‏
919 ‎‡a  metaanalyticapproachestodeterminegenderdifferencesintheageincidencecharacteristicsofschizophreniaandrelatedpsychoses‏ ‎‡A  Meta-analytic approaches to determine gender differences in the age-incidence characteristics of schizophrenia and related psychoses‏ ‎‡9  1‏
919 ‎‡a  migrationandmentalillness‏ ‎‡A  Migration and mental illness‏ ‎‡9  1‏
919 ‎‡a  mindfulnessbasedprogrammesformentalhealthpromotioninadultsinnonclinicalsettingsprotocolofanindividualparticipantdatametaanalysisofrandomisedcontrolledtrials‏ ‎‡A  Mindfulness-based programmes for mental health promotion in adults in non-clinical settings: protocol of an individual participant data meta-analysis of randomised controlled trials‏ ‎‡9  1‏
919 ‎‡a  minocyclinefornegativesymptomsofschizophreniaandpossiblemechanisticactionsthebeneminrct‏ ‎‡A  Minocycline for negative symptoms of schizophrenia and possible mechanistic actions: the BeneMin RCT‏ ‎‡9  1‏
919 ‎‡a  minorphysicalanomaliesacrossethnicgroupsina1episodepsychosissample‏ ‎‡A  Minor physical anomalies across ethnic groups in a first episode psychosis sample‏ ‎‡9  1‏
919 ‎‡a  minorphysicalanomaliesinpatientswith1episodepsychosistheirfrequencyanddiagnosticspecificity‏ ‎‡A  Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity.‏ ‎‡9  1‏
919 ‎‡a  minorphysicalanomaliesinpsychosesassociationswithclinicalandputativeaetiologicalvariables‏ ‎‡A  Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables‏ ‎‡9  1‏
919 ‎‡a  minorphysicalanomaliesinschizophreniaisageaconfoundingfactor‏ ‎‡A  Minor physical anomalies in schizophrenia: is age a confounding factor?‏ ‎‡9  1‏
919 ‎‡a  modafinileffectsoncognitionandemotioninschizophreniaanditsneurochemicalmodulationinthebrain‏ ‎‡A  Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain‏ ‎‡9  1‏
943 ‎‡a  196x‏ ‎‡A  1966‏ ‎‡9  3‏
943 ‎‡a  201x‏ ‎‡A  2018‏ ‎‡9  2‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  BIBSYS|14020423
996 ‎‡2  J9U|987007381269505171
996 ‎‡2  DBC|87097991139758
996 ‎‡2  NTA|071957367
996 ‎‡2  SUDOC|268120609
996 ‎‡2  NKC|utb2011655784
996 ‎‡2  BIBSYS|90200404
996 ‎‡2  BIBSYS|90408808
996 ‎‡2  NII|DA00244978
996 ‎‡2  CAOONL|ncf10583625
996 ‎‡2  NII|DA16103829
996 ‎‡2  BLBNB|000252049
996 ‎‡2  J9U|987009441229605171
996 ‎‡2  DNB|115797094X
996 ‎‡2  RERO|A000095391
996 ‎‡2  NII|DA05275196
996 ‎‡2  LC|n 2017061240
996 ‎‡2  W2Z|1642068411609
996 ‎‡2  NII|DA01916641
996 ‎‡2  CAOONL|ncf10007018
996 ‎‡2  NDL|001193147
996 ‎‡2  RERO|A025765384
996 ‎‡2  BIBSYS|90817366
996 ‎‡2  J9U|987007330376605171
996 ‎‡2  NDL|00444892
996 ‎‡2  NUKAT|n 2011061525
996 ‎‡2  ISNI|0000000023557216
996 ‎‡2  NTA|144025620
996 ‎‡2  LC|no2014075627
996 ‎‡2  LC|no2006040775
996 ‎‡2  ISNI|0000000496848101
996 ‎‡2  NTA|073617261
996 ‎‡2  SUDOC|179427830
996 ‎‡2  NUKAT|n 2018086274
996 ‎‡2  BNF|17843749
996 ‎‡2  SUDOC|169882500
996 ‎‡2  DNB|105405083X
996 ‎‡2  NII|DA18135032
996 ‎‡2  LC|n 85341429
996 ‎‡2  ISNI|0000000442508881
996 ‎‡2  RERO|A006427261
996 ‎‡2  NDL|01145270
996 ‎‡2  ISNI|0000000032650746
996 ‎‡2  NTA|314249656
996 ‎‡2  LC|no2019179939
996 ‎‡2  LC|no2024026537
996 ‎‡2  BIBSYS|10035374
996 ‎‡2  ISNI|0000000506047499
996 ‎‡2  LC|no2001045617
996 ‎‡2  ISNI|0000000031749031
996 ‎‡2  BNF|16181674
996 ‎‡2  J9U|987007323771505171
996 ‎‡2  ISNI|0000000001930518
996 ‎‡2  PLWABN|9813658561805606
996 ‎‡2  NDL|00919226
996 ‎‡2  SUDOC|070986185
996 ‎‡2  LC|n 00122035
996 ‎‡2  NII|DA05091193
996 ‎‡2  NUKAT|n 2007133076
996 ‎‡2  DBC|87097946820401
996 ‎‡2  BIBSYS|9044808
996 ‎‡2  ISNI|000000047689037X
996 ‎‡2  DNB|123749995X
996 ‎‡2  SUDOC|056892802
996 ‎‡2  CAOONL|ncf10366291
996 ‎‡2  LNB|LNC10-000073522
996 ‎‡2  NUKAT|n 2008133132
996 ‎‡2  ISNI|0000000485894428
996 ‎‡2  SUDOC|195393600
996 ‎‡2  NII|DA02395147
996 ‎‡2  J9U|987007450325705171
996 ‎‡2  LC|n 2016056610
996 ‎‡2  DNB|117545236X
996 ‎‡2  ISNI|0000000389037856
996 ‎‡2  BIBSYS|90160819
996 ‎‡2  BIBSYS|90604133
996 ‎‡2  LC|no2015080497
996 ‎‡2  NTA|073644862
996 ‎‡2  DNB|1254883371
996 ‎‡2  SUDOC|257878459
996 ‎‡2  ISNI|0000000067605822
996 ‎‡2  LC|no 96042000
996 ‎‡2  NII|DA14681766
996 ‎‡2  PLWABN|9810578623205606
996 ‎‡2  NUKAT|n 2007003287
996 ‎‡2  DNB|1132099900
996 ‎‡2  CAOONL|ncf10019517
996 ‎‡2  NSK|000494934
996 ‎‡2  SUDOC|251635031
996 ‎‡2  ISNI|0000000075034724
996 ‎‡2  LC|n 81122228
996 ‎‡2  NDL|00469090
996 ‎‡2  ISNI|0000000493355512
996 ‎‡2  LC|no2017155140
996 ‎‡2  LC|n 88282197
996 ‎‡2  NSK|000467999
996 ‎‡2  ISNI|0000000082421052
996 ‎‡2  ISNI|0000000367061345
996 ‎‡2  ISNI|0000000116884080
996 ‎‡2  DNB|170026450
996 ‎‡2  LC|nb2017007298
996 ‎‡2  DNB|1158152507
996 ‎‡2  BIBSYS|90366882
996 ‎‡2  ISNI|0000000383359918
996 ‎‡2  RERO|A013616273
996 ‎‡2  XA|1388
996 ‎‡2  RERO|A012853430
996 ‎‡2  NTA|305642553
996 ‎‡2  DNB|1114693847
996 ‎‡2  BNC|981058511210806706
996 ‎‡2  NII|DA07093666
996 ‎‡2  DNB|13618989X
996 ‎‡2  NTA|071490302
996 ‎‡2  LC|no2022001557
996 ‎‡2  LC|n 83027235
996 ‎‡2  SUDOC|240191889
996 ‎‡2  ISNI|0000000374569980
996 ‎‡2  SUDOC|273585355
996 ‎‡2  LC|n 85170927
996 ‎‡2  BIBSYS|97020587
996 ‎‡2  SELIBR|371711
996 ‎‡2  BIBSYS|90805376
996 ‎‡2  NUKAT|n 2009137512
996 ‎‡2  NSK|000118846
996 ‎‡2  NTA|068329547
996 ‎‡2  LC|nb2022008717
996 ‎‡2  J9U|987007338259605171
996 ‎‡2  LC|n 80082814
996 ‎‡2  LC|n 88044993
996 ‎‡2  ISNI|0000000076932956
996 ‎‡2  NSK|000251524
996 ‎‡2  CAOONL|ncf11235511
996 ‎‡2  LC|no2012021537
996 ‎‡2  ISNI|0000000052872557
996 ‎‡2  NUKAT|n 2008127436
996 ‎‡2  RERO|A003944102
996 ‎‡2  LC|n 78062681
996 ‎‡2  BIBSYS|90219941
996 ‎‡2  BIBSYS|3081460
996 ‎‡2  ISNI|0000000073776265
996 ‎‡2  NII|DA03375021
996 ‎‡2  LC|nb2018011462
996 ‎‡2  PLWABN|9810632275705606
996 ‎‡2  ISNI|0000000039866240
996 ‎‡2  ISNI|0000000403465815
996 ‎‡2  LC|n 86844909
996 ‎‡2  RERO|A003430025
996 ‎‡2  RERO|A003430024
996 ‎‡2  LC|n 83210727
996 ‎‡2  RERO|A003430026
996 ‎‡2  RERO|A003430021
996 ‎‡2  RERO|A003430020
996 ‎‡2  RERO|A003430023
996 ‎‡2  RERO|A003430022
996 ‎‡2  BIBSYS|90501991
996 ‎‡2  BNF|15868260
996 ‎‡2  NII|DA12529319
996 ‎‡2  PLWABN|9810563118305606
996 ‎‡2  ISNI|000000043467234X
996 ‎‡2  BNF|15678494
996 ‎‡2  SUDOC|277348439
996 ‎‡2  LC|n 2020035857
996 ‎‡2  B2Q|0001598121
996 ‎‡2  BNF|12368443
996 ‎‡2  RERO|A012514363
996 ‎‡2  LC|n 92122471
996 ‎‡2  J9U|987007366026505171
996 ‎‡2  NII|DA01258978
996 ‎‡2  ISNI|000000049686921X
996 ‎‡2  J9U|987007449272605171
996 ‎‡2  SUDOC|256789878
996 ‎‡2  PLWABN|9814255918605606
996 ‎‡2  ISNI|0000000408721494
996 ‎‡2  LC|n 97060719
996 ‎‡2  NII|DA0747504X
996 ‎‡2  SIMACOB|194333539
996 ‎‡2  LC|nb2006002125
996 ‎‡2  SUDOC|074217976
996 ‎‡2  LC|n 90630984
996 ‎‡2  PLWABN|9810641764905606
996 ‎‡2  SUDOC|189591811
996 ‎‡2  NII|DA05589208
996 ‎‡2  BNF|16919030
996 ‎‡2  BIBSYS|14065646
996 ‎‡2  DNB|1011623552
996 ‎‡2  SUDOC|274025639
996 ‎‡2  SUDOC|115075542
996 ‎‡2  LC|n 83038540
996 ‎‡2  LC|n 80086589
996 ‎‡2  J9U|987007378722905171
996 ‎‡2  ISNI|0000000424675029
996 ‎‡2  LC|nb2018005198
996 ‎‡2  NUKAT|n 2014093553
996 ‎‡2  BIBSYS|98030108
996 ‎‡2  BNF|17889640
996 ‎‡2  LNB|LNC10-000297697
996 ‎‡2  ISNI|0000000027161294
996 ‎‡2  NUKAT|n 97028467
996 ‎‡2  CAOONL|ncf10136140
996 ‎‡2  BIBSYS|97004126
996 ‎‡2  CAOONL|ncf11162465
996 ‎‡2  SUDOC|272304549
996 ‎‡2  SUDOC|147133025
996 ‎‡2  LC|no 98017359
996 ‎‡2  DNB|1158133545
996 ‎‡2  ISNI|000000002946116X
996 ‎‡2  NUKAT|n 2006105780
996 ‎‡2  LC|n 84238708
996 ‎‡2  CAOONL|ncf11910907
996 ‎‡2  SUDOC|261690612
996 ‎‡2  LC|n 85366108
996 ‎‡2  NII|DA19381657
996 ‎‡2  BNF|12090625
996 ‎‡2  PLWABN|9810559458105606
996 ‎‡2  NUKAT|n 01717286
996 ‎‡2  J9U|987007434989905171
996 ‎‡2  BIBSYS|2093202
996 ‎‡2  DBC|87097969538894
996 ‎‡2  LC|n 85152443
996 ‎‡2  ICCU|PARV403638
996 ‎‡2  ISNI|0000000395486826
996 ‎‡2  DNB|121966143
996 ‎‡2  BIBSYS|90322516
996 ‎‡2  LC|no 00019775
996 ‎‡2  RERO|A003015896
996 ‎‡2  LC|n 2012072674
996 ‎‡2  NII|DA05900698
996 ‎‡2  BIBSYS|1560455415803
996 ‎‡2  RERO|A012425776
996 ‎‡2  NII|DA06014223
996 ‎‡2  LC|no 97006732
996 ‎‡2  ISNI|0000000067568486
996 ‎‡2  BIBSYS|90913562
996 ‎‡2  BNF|12404007
996 ‎‡2  BAV|495_22896
996 ‎‡2  PTBNP|211810
996 ‎‡2  BIBSYS|8023581
996 ‎‡2  NII|DA01170094
996 ‎‡2  ISNI|0000000372264200
996 ‎‡2  LC|n 2010010486
996 ‎‡2  NII|DA04424643
996 ‎‡2  ISNI|0000000117267754
996 ‎‡2  BNF|17965838
996 ‎‡2  LIH|LNB:BNT_k_;=B_l_
996 ‎‡2  BIBSYS|14050305
996 ‎‡2  SUDOC|052480852
996 ‎‡2  NDL|032862970
996 ‎‡2  NTA|068736746
996 ‎‡2  BNC|981058524594306706
996 ‎‡2  J9U|987007387395405171
997 ‎‡a  1960 0 lived 0000 0‏ ‎‡9  1‏
998 ‎‡a  Jones, Peter Brian‏ ‎‡2  NUKAT|n 2007133076‏ ‎‡3  suggested‏ ‎‡3  viafid‏
998 ‎‡a  Jones, Peter B.‏ ‎‡2  BIBSYS|4091608‏ ‎‡3  viafid‏
998 ‎‡a  Jones, Peter B.‏ ‎‡q  (Peter Brian),‏ ‎‡2  LC|no2003084028‏ ‎‡3  suggested‏ ‎‡3  title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')‏
998 ‎‡a  Jones, Peter B.‏ ‎‡q  (Peter Brian),‏ ‎‡2  J9U|987007370891405171‏ ‎‡3  suggested‏ ‎‡3  title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')‏
998 ‎‡a  جونز، بيتر ب.،‏ ‎‡2  J9U|987007370891405171‏ ‎‡3  suggested‏ ‎‡3  title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')‏
998 ‎‡a  Jones, Peter B‏ ‎‡2  ISNI|0000000119535791‏ ‎‡3  suggested‏
998 ‎‡a  Jones, Peter B.‏ ‎‡2  ISNI|0000000119535791‏ ‎‡3  suggested‏
998 ‎‡a  Jones, Peter Brian‏ ‎‡2  ISNI|0000000119535791‏ ‎‡3  suggested‏
998 ‎‡a  Jones, Peter B.‏ ‎‡2  ISNI|0000000119535791‏ ‎‡3  suggested‏
998 ‎‡a  Jones, Peter B.‏ ‎‡2  DNB|1011623552‏ ‎‡3  suggested‏
998 ‎‡a  Jones, Peter B.‏ ‎‡2  SUDOC|070986185‏ ‎‡3  suggested‏
998 ‎‡a  Jones, Peter Brian‏ ‎‡2  PLWABN|9810563118305606‏ ‎‡3  viafid‏
998 ‎‡a  Jones, Peter B.‏ ‎‡2  SZ|1011623552‏ ‎‡3  partial date, partial title‏
998 ‎‡a  Jones, Peter B.‏ ‎‡q  (Peter Brian),‏ ‎‡2  CAOONL|ncf12118371‏ ‎‡3  title: (0.89, 'europeanschizophreniaoutpatienthealthoutcomessohostudy', 'europeanschizophreniaoutpatienthealthoutcomessohostudyrationalemethodsandrecruitment')‏